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ABSTRACT 
Sleep is a critical component of healthy developing during adolescence, and when 
disrupted, has been linked to difficulties with physical status, psychological health, family 
functioning, neuropsychological symptoms, and academic performance. The overarching goal of 
this project was to examine sleep-wake disturbances in association with bio-neuropsychosocial 
functioning in a vulnerable pediatric population of adolescents with spina bifida (SB).  
Specifically, this study aimed to 1) examine sleep-wake patterns in adolescents with SB using a 
multimodal sleep assessment, 2) identify daily temporal associations between sleep and pain as 
well as sleep and mood, and 3) identify the relationship between sleep-wake disturbances and 
bio-neuropsychosocial functioning in adolescents with SB. Sleep-wake patterns in adolescents 
ages 12 to 18 with SB (N = 37) were compared to a matched comparison group of typically 
developing (TD) peers (N = 37). A subjective and objective sleep assessment was conducted; 
ambulatory actigraphy recordings was completed over 10 days, and adolescents completed 
several sleep questionnaires (e.g., sleep quality, pre-sleep arousal) and a daily diary. In addition, 
adolescents and parents completed questionnaires to assess physical (pain, BMI), psychological 
(internalizing symptoms, health-related quality of life), family (conflict, cohesion), 
neuropsychological (attention, executive function), and academic functioning (school 
competence, grades).  
Study findings revealed that adolescents with SB experienced higher rates of sleep-wake 
disturbances compared to their typically developing peers. Results of actigraphy and 
  
viii 
questionnaire report data found that adolescents were particularly at-risk for reduced sleep 
quantity (i.e., lower total sleep time) and poor sleep quality (i.e., difficulties with bedtime settling 
and staying asleep). Adolescents with SB also experienced higher levels of daytime fatigue 
compared to their peers. Sleep-wake disturbances were associated with every domain of 
adolescent functioning within the bio-neuropsychosocial model. In particular, there were 
consistent data to support the connection between nighttime sleep disturbances and 
psychological maladjustment (i.e., internalizing, quality of life). To a lesser extent, nighttime 
sleep disturbances were linked to worse physical health (pain, BMI) and family functioning 
(family conflict). Furthermore, daytime sleepiness and/or fatigue, but not nighttime sleep 
disturbances, predicted worse neuropsychological and academic functioning, including 
inattention/hyperactivity, executive dysfunction, and lower school grades. Ongoing evaluation 
and treatment of sleep disturbances will be critical to optimize health and functioning in this 
vulnerable pediatric population.
  
1 
CHAPTER ONE 
INTRODUCTION 
Overview 
Sleep is a critical aspect of adolescent development, and is associated with multiple 
domains of adolescent functioning (Mindell & Owens, 2010; Figure 1). Specifically, poor 
nighttime sleep may adversely impact key bio-neuropsychosocial outcomes, including youths’ 
physical, psychological, family, and neuropsychological functioning (e.g., pain, mood, attention; 
Alfano, Zakem, Costa, Taylor & Weems, 2009; Chen, Beydoun & Wang, 2008; Kheriandish & 
Gozal, 2006). Research also indicates a bidirectional relationship between sleep and poor 
daytime functioning; sleep may contribute to pain and mood disturbance, which, in turn, may 
exacerbate sleep disruptions (Figure 2; Dahl & Lewin, 2002; Valrie, Bromberg, Palermo & 
Schanberg, 2013). Sleep-wake disturbances are characterized by nighttime sleep disruption and 
daytime sleepiness (e.g., frequent nighttime awakenings, exces sive daytime fatigue), and are 
especially prevalent in youth with chronic illnesses and medical conditions (e.g., Hysing, 
Sivertsen, Stormark, Elgen & Lundervold, 2009). Adolescents with spina bifida (SB), a 
congenital neural tube defect, are at-risk for sleep-wake disturbances (Quine, 1991) in addition to 
poor physical, psychological, family, and neuropsychological functioning (Appleton, 1997; 
Clancy, McGrath, & Oddson, Holmbeck et al., 2003; Holmbeck et al., 2010; Rose & Holmbeck, 
2007). However, few studies have comprehensively assessed the relationship between sleep-
wake disturbances and key bio-neuropsychosocial outcomes in adolescents with SB. The current 
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study sought to bridge this critical gap in knowledge through a comprehensive examination of 
sleep-wake disturbances as predictors of bio-neuropsychosocial functioning in this vulnerable 
pediatric population. 
Figure 1. Theoretical Model of the Associations between Sleep-wake Disturbances and 
Adolescent Bio-neuropsychosocial Functioning 
 
Figure 2. Daily Associations between Adolescent Sleep, Mood, and Pain 
 
The following sections provide an overview of the literature on sleep in adolescence, the 
definition and assessment of sleep-wake disturbances, and sleep-wake disturbances in youth with 
3 
 
 
chronic medical illnesses and in youth with SB in particular. Research on associations between 
sleep and adolescent bio-neuropsychosocial outcomes is reviewed and applied to youth with SB. 
Finally, the current study is described along with the specific aims and hypotheses of the 
proposed project.  
Sleep in Adolescence 
Alterations in sleep patterns and the timing of sleep are normative features of adolescence 
(Carskadon & Tarokh, 2013). Adolescent sleep patterns are often referred to as the “perfect 
storm” to describe how several bio-neuropsychosocial factors decrease total sleep time, delay the 
timing of sleep, and increase daytime fatigue and sleepiness (Carskadon, 2011). Adolescents 
have been shown to need about 9 hours of sleep according to laboratory studies (Carskadon & 
Acebo, 2002), yet most sleep only about 7 hours per night (Wolfson & Carskadon, 1998). 
Therefore, the loss of sleep during this developmental period is not the result of a lower need for 
sleep. Instead, dramatic changes in adolescent sleep patterns arise from a convergence of 
biological and psychosocial influences.  
Data on biological regulation of sleep during adolescence indicate that adolescents 
develop a sleep phase delay of about two hours (i.e., later sleep onset and wake times) around the 
time of puberty onset (Carskadon & Acebo, 2002). Developmental and psychosocial factors may 
further exacerbate sleep delay and decrease the overall time adolescents spend sleeping. For 
example, developmentally normative adolescent strivings to achieve independence by self-
selecting bedtimes may contribute to delayed sleep onset (Carskadon, 2011). Screen 
time/technology use in the bedroom, academic responsibilities, extracurricular activities, and 
social opportunities also tend to increase during adolescence and may further contribute to later 
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bedtimes and sleep loss (Cain & Gradisar, 2010; Carskadon, 2011). Changes in sleep patterns 
during this developmental period are also often accompanied by nighttime and daytime sleep 
disturbances, including daytime sleepiness and fatigue (Carskadon, 1990; ter Wolbeek, van 
Doornen, Kavelaars, & Heijnen, 2006), increased napping (Shinkoda, Matsumoto, Park, & 
Nagashima, 2000), and difficulties initiating and maintaining sleep (i.e., insomnia symptoms; 
Roberts, Lee, Hermandez, & Solari, 2004). Between 6-10% of adolescents are considered to 
have DSM-defined insomnia (Roberts, Roberts & Chan, 2008; Johnson, Roth, Schultz, & 
Breslau, 2006), adding to growing evidence that clinically significant sleep disorders among 
adolescents have prevalence rates comparable to major psychiatric disorders (e.g., mood and 
behavioral disorders; Roberts et al., 2008). Further, sleep disturbances may also become chronic; 
several studies have indicated that sleep disturbances persist or recur over time (Morrison, 
McGee, & Stanton, 1992; Roberts et al., 2008). Thus, early identification and treatment of sleep 
disturbances may be particularly beneficial.  
Definition and Assessment of Sleep Disturbances 
Sleep is a multidimensional construct. Nighttime sleep disturbances in adolescents can be 
categorized as 1) inadequate sleep quantity for age (i.e., insufficient sleep), 2) poor sleep quality 
(i.e., fragmented sleep), and sleep disorders such as those involving inappropriate timing of sleep 
(i.e., circadian rhythm and primary sleep disorders; Mindell & Owens, 2010). For the current 
research project, the majority of the measured sleep constructs fit under the first two categories 
of nighttime sleep disturbances (see Figure 3). Insufficient sleep is typically the result of 
difficulty initiating (i.e., delayed sleep onset) and/or maintaining sleep (i.e., prolonged or 
frequent nocturnal awakenings) with the result being inadequate sleep quantity (Mindell & 
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Owens, 2010). Sleep fragmentation often involves brief and frequent arousals during sleep 
(Mindell & Owens, 2010). Further, daytime sleep disturbances may include frequent napping 
excessive sleepiness, and fatigue (Carskadon, 1990; ter Wolbeek et al., 2006). While closely 
related, fatigue and sleepiness are distinct constructs. In the current study, sleep-wake 
disturbances are defined as both nighttime and daytime sleep disturbance, such as nighttime 
sleep fragmentation and daytime fatigue.  
Figure 3. Study Model of the Associations between Sleep-wake Disturbances and Bio-
neuropsychosocial Functioning in Adolescents with Spina Bifida 
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Accurate assessment of sleep-wake disturbances in children and adolescents is important 
across research and clinical settings. Due to the multidimensional nature of sleep, evaluation of 
sleep disturbances in children and adolescents often requires a combination of objective and 
subjective sleep assessment tools (Lewandowski, Toliver-Sokol & Palermo, 2011), which are 
briefly described in the following section.  
Objective Sleep Measurement  
The most widely used tools for objective measurement of sleep include polysomnography 
(PSG) and actigraphy. PSG is a diagnostic test that is typically performed in a sleep laboratory, 
yielding information on sleep architecture (e.g., distribution of sleep stages) and physiological 
changes (e.g., eye and body movement, heart rate) that occur during sleep (Mindell & Owens, 
2010). Clinicians often use PSG to diagnose the presence and severity of sleep-disordered 
breathing (SDB), including obstructive sleep apnea (OSA; Mindell & Owens, 2010). OSA is a 
respiratory disorder characterized by partial or complete obstruction to the upper airway, 
resulting in sleep fragmentation (Witmans & Young, 2013). Pediatric medical conditions often 
associated with OSA include craniofacial syndromes, myelomeningocele, Down syndrome, 
obesity, and sickle cell disease (Mindell & Owens, 2010). 
While PSG is considered the gold standard for sleep assessment (Horne & Biggs, 2013), 
there are several limitations to using this type of sleep data collection. PSG is conducted in a 
laboratory setting that may alter a participant’s typical sleep patterns, is costly, and may be both 
time-consuming and labor intensive (Horne & Biggs, 2013). A popular alternative to PSG for 
assessing pediatric sleep is actigraphy. In fact, overall agreement rates of 89% to 97% between 
actigraphy and PSG have been found in children ages 3-18 (Meltzer, Walsh, Traylor & Westin, 
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2012). Actigraphy uses an actiwatch with an accelerometer (i.e., a portable wristwatch-like 
device) to record the presence or absence of movement as an approximation of sleep and wake 
cycles (Horne & Bigg, 2013). In other words, the presence of movements indicates wakefulness 
and the absence of movements indicates sleep. Actiwatch data are coded and analyzed using 
specialized computer software and trained research assistants to approximate sleep-wake patterns 
(Horne & Bigg, 2013). While actigraphy coding does involve some subjective decisions (e.g., 
distinguishing daytime periods of quiet wakefulness versus naps), this assessment tool enables 
researchers and clinicians to gain a clear picture of sleep-wake behavior (e.g., sleep quantity, 
nocturnal awakenings) in a naturalistic setting (Mindell & Owens, 2010).  
Objective sleep measurement tools may be used in conjunction with questionnaire 
measures to provide a comprehensive examination of sleep in youth. Questionnaire measures and 
sleep diaries are often dependent on the accuracy and reliability of the person completing them, 
and thus may have a number of limitations (Horne & Biggs, 2013).  As such, it has become 
standard practice for self-report sleep diaries to be used at the same time as actigraphy recording 
for greater reliability in reporting sleep/wake patterns as well as to aid in the coding and analyses 
of sleep-wake patterns (e.g., determination of nap periods; Horne & Biggs, 2013). Moreover, 
while actigraphy provides information about sleep patterns, this methodology is unable to 
identify behavioral sleep disturbances (e.g., insomnia) or potential reasons for difficulty falling 
asleep (e.g., pre-sleep habits and cognitions). Therefore, due to the multidimensional nature of 
sleep, the use of both objective (i.e., actigraphy) and subjective (i.e., questionnaires, sleep 
diaries) sleep measurement tools is essential. 
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Subjective Sleep Measurement 
Developmentally appropriate questionnaire measures of sleep disturbances are an 
essential component of sleep assessment. A recent review article by Lewandowski and 
colleagues (2011a) identified several subjective pediatric sleep measures that fell into the 
following categories: 1) daytime sleepiness, 2) sleep habits or hygiene, 3) attitudes and 
cognitions associated with sleep, 4) sleep initiation and maintenance, 5) and multidimensional 
constructs. Measures of daytime sleepiness (e.g., Pediatric Daytime Sleepiness Scale; Drake et 
al. 2013) typically assess behaviors such as falling asleep and alertness during the day, while 
measures of fatigue (e.g., the Pediatric Quality of Life Inventory- Fatigue; Varni, Burwinkle, & 
Szer, 2004) may include items related to general feelings of tiredness, need for rest during the 
day, and cognitive fatigue (Varni et al., 2004). Measures of sleep hygiene and sleep habits (e.g., 
the Adolescent Sleep Hygiene Scale; LeBourgeois, Giannotti, Cortesi, Wolfson & Harsh, 2005) 
examine bedtime routines, activities surrounding bedtime, and the sleep environment 
(Lewandowski et al., 2011a). Measures of sleep-related beliefs and cognitions (e.g., the Pre-sleep 
Arousal Survey for Children; Gregory, Willis, Wiggs, & Harvey, 2008) examine children’s 
dysfunctional thoughts about sleep (e.g., worry about falling asleep) as well as somatic arousal 
(e.g., rapid pulse, sweating palms) prior to sleep onset (Lewandowski et al., 2011a). Measures of 
sleep initiation and sleep maintenance (e.g., the Adolescent Sleep Wake Scale; LeBourgeois et 
al., 2005) examine sleep quantity and difficulties with falling and staying asleep. Self-reported 
sleep diaries are also often used to assess sleep-wake patterns in children and adolescents, in 
which bedtime, the time the adolescent went to sleep, the number and duration of nocturnal 
awakenings, the time the child awoke in the morning, and any daytime napping are recorded 
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over a 1-2 week period of time (Horne & Biggs, 2013). Multidimensional pediatric sleep 
measures (e.g., the Pediatric Sleep Questionnaire, Chervin, Hedger, Dillon, & Pituch, 2000) may 
assess a broad range of sleep disturbances including sleep habits, fatigue, sleepiness, symptoms 
of sleep-disordered breathing (e.g., snoring), and nocturnal awakenings (Lewandowski et al., 
2011a). 
Sleep Disturbances in Youth with Chronic Medical Illnesses 
Assessment of sleep is particularly important for pediatric populations, due to the 
increased risk of sleep disruption among youth with acute and chronic medical conditions
 
(Lewandowski, Ward & Palermo, 2011). Sleep disturbances occur more frequently in children 
with acute and chronic medical illnesses compared to otherwise healthy or TD peers (Hysing et 
al., 2009). Sleep disturbances are also more likely to become chronic and persistent in youth with 
chronic conditions compared to those without chronic conditions (Sivertsen, Hysing, Elgen, 
Stormark, & Lundervold, 2009). Comprehensive sleep assessments in pediatric populations have 
expanded in the past decade, identifying disturbed sleep as a prevalent concern across several 
pediatric medical illnesses: youth with asthma
 
(Sadeh, Horowitz, Wolach-Benodis, & Wolach, 
1998), cancer (Hinds et al., 2007), chronic pain conditions (Palermo, Toliver-Sokol, Fonareva, & 
Koh, 2007), craniofacial abnormalities (e.g., cleft palate, MacLean, Fitzsimons, Hayward, 
Waters & Fitzgerald, 2008), sickle cell disease (Jacob, Miaskowski, Savedra, Beyer, Treadwell, 
& Styles, 2006), cystic fibrosis (Amin, Bean, Burklow, & Jeffries, 2005), and neurological 
conditions (e.g., epilepsy; Maganti, Hausman, Koehn, Sandok, Glurich & Mukesh, 2006). In 
particular, youth with chronic illnesses may achieve less nighttime sleep and report more 
difficulties initiating and maintaining sleep compared to TD peers
 
(Hysing et al., 2009).  
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Various aspects of a chronic Illness may affect sleep; specifically, physical and disease-
related mechanisms of the illness (e.g., BMI, pain, airway restriction), hospitalization, and 
medication may all significantly impact sleep (Lewandowski et al., 2011b). Certain brain 
structures are also connected to sleep, including the hypothalamus, brain stem, and basal 
forebrain, all of which can be impacted by brain tumors, neurological conditions, and illness 
treatments (e.g., chemotherapy; Rosen, Shor & Geller, 2008). Medical illnesses such as asthma 
and epilepsy may have worse symptoms at night, and others (e.g., diabetes) require nighttime 
medication (Hysing et al., 2009). Further, some medical conditions are associated with particular 
sleep disorders (e.g., sleep disordered breathing and spina bifida, Waters et al., 1998). 
Conversely, diminished sleep quantity and quality may exacerbate a chronic illness and disease-
related symptomatology
 
(Lewandowski et al., 2011b). Supporting this, Hanson and Chen (2008) 
found that worse self-reported sleep quality predicted poorer lung function in youth with asthma 
the following day. Thus, the impact of sleep disturbances in youth with chronic medical 
conditions may be more concerning given potential bidirectional relations between sleep and 
health. Poor sleep may worsen the medical condition, and, in turn, disease-related symptoms 
may exacerbate sleep disturbances (e.g., asthma and cystic fibrosis; Hanson & Chen, 2008; Amin 
et al., 2005).  
Sleep Disturbances in Youth with Spina Bifida 
Despite their importance, relatively little research attention has been directed toward 
assessing sleep disturbances in youth with spina bifida (SB). SB is a relatively common 
congenital neural tube defect, occurring in 18 out of 100,000 births in the United States (Centers 
for Disease and Control Prevention, 2010). This condition arises due to the failed closure of one 
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or more vertebrae surrounding the embryo’s developing spinal cord, and is associated with 
varying degrees of motor impairment, neuropsychological deficits, and difficulties with bladder 
and bowel management (Liptak 1997). In children and adolescents with SB, studies have 
revealed the presence of behavioral sleep problems including insomnia symptoms (e.g., difficulty 
initiating and maintaining sleep; Quine 1991; Edelstein, Cirino, Hasher & Fletcher, 2012) as well 
as physiological sleep disorders such as central and obstructive sleep disordered breathing (SDB; 
Waters et al., 1998; Kirk, Morielli & Brouillette 1999). High rates of SDB and other sleep 
disturbances in this population may be due to central nervous system malformations and 
pulmonary function abnormalities (Waters et al., 1998). Despite research indicating a high 
incidence of sleep problems across several illness groups, studies that assess sleep in adolescents 
with SB remain scarce. Multi-method studies that comprehensively assess sleep-wake 
disturbances using objective (i.e., actigraphic) and subjective sleep instruments are essential for 
characterizing the nature of these problems.  
Associations between Sleep and Adolescent Bio-neuropsychosocial Functioning (Figure 3) 
Sleep is a critical aspect of adolescent development and may be associated with several 
domains of adolescent functioning (Figures 1 & 3). While adolescents with SB are at-risk for 
physical, psychological, family, and neuropsychological difficulties, few studies have examined 
the link between sleep and relevant bio-neuropsychosocial domains in this population. Further, 
due to increased numbers of individuals with SB surviving into adulthood, and the impediment 
that bio-neuropsychosocial difficulties may have on self-management in chronic illness 
populations (Gadalla, 2008), research investigating sleep as a modifiable behavioral mechanism 
that may improve functioning in adolescents with SB is essential.  
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Sleep and Physical Functioning 
Research on sleep and physical health has tended to focus on two important physical 
health parameters: pain and weight status or obesity.   
Sleep and pain. Persistent or recurring pain is common among adolescents, occurring in 
25-40% of community samples (Stanford, Chambers, Biesanz, 2008). Pain may be part of a 
medical condition’s presentation (e.g., sickle cell disease, juvenile idiopathic arthritis), or the 
condition itself (e.g., migraine headaches; Valrie et al., 2013). Youth with persistent or recurrent 
pain often complain of disturbed sleep, characterized by difficulties initiating or maintaining 
sleep and shorter sleep quantity (i.e., insufficient sleep), poor subjective sleep quality, and poor 
sleep hygiene. Beyond the difficulty of initiating and maintaining sleep when experiencing 
painful somatic symptoms, increased commonality of sleep disturbances in pediatric pain 
populations may be due to medications (e.g., analgesics) and hospitalizations that affect sleep 
(Lewandowski et al., 2011b). 
The sleep-pain association has been well documented in adult and pediatric pain 
populations, with the majority of studies finding evidence of bidirectionality (see review; Valrie 
et al., 2013). Review articles of adult and pediatric literature have found evidence that pain 
disrupts sleep, and poor sleep may exacerbate pain (Figure 3; Onen, Onen, Courpron et al, 2005; 
Valrie et al., 2013), possibly by increasing pain sensitivity (Lautenbacher, Kundermann & Krieg, 
2006; Smither, Edwards & McCann, 2007). In juvenile idiopathic arthritis (JIA), sickle cell 
disease (SCD), headache, and mixed pediatric pain samples, cross-sectional objective (i.e., PSG 
and actigraphy) and questionnaire-based sleep assessments have generally found that greater 
pain intensity and frequency is associated with greater sleep disruption (Valrie et al., 2013). In a 
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daily diary study of youth with SCD ages 8 to 12 years, investigators found that higher pain 
intensity predicted poor sleep quality that night, and, conversely, poorer sleep quality predicted 
higher pain intensity the following day (Valrie, Gil, Redding-Lallinger, & Daeschner, 2007). 
Yet, other diary studies of children with JIA and adolescents with idiopathic chronic pain have 
discovered that pain intensity did not predict sleep quality, but poor sleep quality did predict 
higher pain intensity the following day (Bromberg, Gil, & Schanberg, 2012; Lewandowski, 
Palermo, De la Motte et al., 2010). These findings may highlight the complex nature of sleep and 
pain. Moreover, each chronic medical illness is characterized by a unique clinical profile that 
may contribute to variation in findings.  
Sleep and weight status/BMI.  Pediatric obesity is considered a worldwide epidemic 
and has risen dramatically in the past several decades; recent estimates indicate that about 30% 
of children and adolescents in the United States are overweight or obese (i.e., BMI greater or 
equal to the 85
th
 percentile; Center for Disease and Control and Prevention, 2011). Given the rise 
of obesity and its association with medical (e.g., type 2 diabetes, cardiovascular disease; 
Freedman, Dietz, Srinivasan, & Berenson, 1999; Ludwig & Ebbeling, 2001) and psychosocial 
risk factors (e.g., poorer health-related quality of life; Wardle & Cooke, 2005), increased 
attention has been paid to prevention and intervention efforts. Effective treatment approaches for 
pediatric obesity typically combine dietary, physical activity, and behavioral components to 
achieve reductions in body mass index (BMI; Oude et al., 2009). These treatment approaches are 
promising, yet, despite their effectiveness, they often do not yield enough weight losses to help 
children and adolescents achieve healthy weight status (Hart, Hawley, Kuhl, & Jelalian, 2013). 
Thus, identification of other modifiable behaviors associated with weight loss in children may be 
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imperative to enhance current treatment approaches (Hart et al., 2013).  
Sleep has been identified as one such target. With the rise of pediatric obesity, there has 
been a parallel decrease in child and adolescent sleep quantity (Matricciani, Olds & Perkov, 
2011). In support of this trend, meta-analyses of cross-sectional and longitudinal studies 
demonstrate that shorter sleep times in childhood is associated with a 58-89% increased risk of 
obesity (Cappuccio, Taggart, Kandala, & Currie, 2008; Chen, Beydoun & Wang, 2008) after 
controlling for race, ethnicity, age, sex, parent BMI, and birth weight (Cappuccio et al., 2008; 
Chen, Beydoun & Wang, 2008). Mechanisms underlying the sleep-obesity link are unclear, yet 
experimental research in adults suggests that strong associations between reduced sleep and 
weight gain may be due to neuroendocrine changes. For example, sleep restriction may lead to 
hormonal fluctuations, including decreased leptin (Spiegel et al., 2004; Teheri, Lin, Austin, 
Young & Mignot, 2004) and increases ghrelin (Teheri et al., 2004) that are associated with the 
regulation of hunger and appetite (Wren at al., 2001; Mars, De Graaf, De Groot, Van Rossum, & 
Kok, 2005).  
Physical Functioning in Youth with SB 
Adolescents with SB are at-risk for poor physical health, including increased rates of 
chronic pain and obesity. Pain is a common experience for adolescents (Stanford et al., 2008), 
and there is evidence to suggest that children, adolescents, and young adults with SB experience 
recurrent pain that may impact their health-related quality of life and psychological health (i.e., 
depression and anxiety; Oddson, Clancy, & McGrath, 2006; Bellin et al., 2010; Bellin et al., 
2013). Clancy and colleagues (2005) found that about half of their sample (56%) of children and 
adolescents with SB (ages 8 to 19 years) experienced pain once per week or more often, which is 
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higher than prevalence rates of weekly pain reported in a population-based studies of TD youth 
(Stanford et al., 2008). Further, over half of the sample reported moderate to severe pain at one 
or more locations (Clancy, McGrath, & Oddson, 2005). The type and location of pain in youth 
with SB may be due to medical sequelae related to this condition. Specifically, youth may 
experience joint and musculoskeletal pain due to the long-term effects of spasticity and 
overusing certain muscle groups necessary for ambulation (e.g., shoulder pain due to wheelchair 
overuse, Marge, 1994), back and lower body pain due to tethered cord (Bowman, McLone, 
Grant, Tomita, & Ito, 2001), and headache and migraine due to intracranial pressure imbalances 
and shunt infection or malfunction (Stellman-Ward, Bannister, Lewis & Shaw, 1997). 
Children and adolescents with SB are also at risk for obesity and overweight. Obesity 
rates (BMI-percentile greater than or equal to the 95th percentile) among individuals with SB 
have been assessed with a variety of methods and range widely from 37-58% in children and 
adolescents, with many more being overweight (BMI-percentile between the 85th and 95th 
percentile; Essner, Murray, & Holmbeck, 2014; Mita, Akataki, Itoh, Ono, Ishida, & Oki, 1993; 
van den Berg-Emons, Bussmann, Meyerink, Roebroeck, & Stam, 2003). Causes of obesity in 
this population are not well-researched, yet non-ambulatory status, sedentary lifestyle, 
neuroendocrine disturbances related to hydrocephalus and Chiari malformation, and short stature 
have been identified as potential implicating factors (Dosa et al., 2009). Further, caring for a 
child with obesity in addition to having a physical disability may impose greater demands on the 
caregiver in performing activities of daily living or medical management tasks as well as 
increase health care costs (Young, Steele, Fehlings, Jutai, Olmsted & Williams, 2005). 
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Sleep and Psychological Functioning 
Sleep disturbances are intricately connected to adolescent psychological functioning. 
Much of research to date has focused on associations between sleep disturbances and 
internalizing symptoms, yet emerging research has also supported links between sleep 
disturbances and broader areas of adolescent psychological health, including health-related 
quality of life.  
Sleep and internalizing symptoms. Researchers have often noted the bidirectional 
nature of sleep and internalizing symptoms (i.e., symptoms of anxiety and depression); sleep 
disturbances may have a negative impact on mood, and subsequent emotional difficulties may 
interfere with sleep, thus creating a negative feedback cycle (Dahl & Lewin, 2002; Figure 2). 
Research has consistently demonstrated associations between disturbed sleep and internalizing 
symptoms in typically adolescents, such that sleep disturbances are associated with increased 
levels of anxiety and depression (Alfano, Zakem, Costa, Taylor & Weems, 2009; Moore et al., 
2009; Roberts, Roberts, & Chen, 2001; Roberts, Roberts & Chen, 2002). Further, internalizing 
symptoms frequently co-occur with sleep disorders (e.g., insomnia; Johnson, Roth, & Breslau, 
2006; Ohayon, Caulet, & Lemoine, 2012), and likewise, sleep disturbances are common in youth 
with mood disorders (e.g., depression and anxiety; Alfano, Ginsburg, & Kingery, 2007; Murray, 
Murphy, Palermo, & Clarke, 2012; see Chorney, Detweiler, Morris, & Kuhn, 2008 for a review). 
For example, adolescents with Major Depressive Disorder (MDD) often report symptoms of 
insomnia, poor sleep quality, and fatigue (Murray et al., 2012).  
Although research is less substantial, the relation between sleep and internalizing 
symptoms has also been assessed in mixed samples of pediatric chronic conditions as well as 
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illness-specific samples. In a population-based study, Hysing and colleagues (2009) found that 
difficulties initiating and maintaining sleep predicted emotional difficulties in a mixed sample of 
youth with chronic illnesses (e.g., asthma, epilepsy, and SB). Sleep disturbances have also been 
shown to be predictive of internalizing symptoms in children with asthma (Fagnano et al., 2009), 
epilepsy (Becker, Fennell, & Carney, 2004), and chronic pain conditions (Palermo & Krista, 
2005; Meltzer, Logan, & Mindell, 2005). Despite emerging evidence of the impact of sleep 
disturbances on internalizing symptoms in TD and pediatric medical populations, these 
associations have not yet been investigated in youth with SB.  
Sleep and health-related quality of life. Although current investigations have found that 
sleep disturbances are associated with specific impairments daytime functioning (e.g., behavior 
problems, depression), there are relatively few studies that have investigated the association 
between sleep disturbances and more global measures of functioning such as health-related 
quality life (HRQOL). Existent literature has tended to evaluate this association within the 
context of pediatric sleep disorders, finding that youth with SDB and insomnia are at-risk for 
significantly greater decrements in physical and psychosocial HRQOL (Hart, Palermo & Rosen, 
2005; Rosen, Palermo, Larkin & Redline, 2002). Even youth with mild to moderate symptoms of 
SDB may be at-risk for reduced physical HRQOL (Rosen et al., 2002), and investigators have 
theorized that physiological sleep disorders such as SDB may impact sleep quality that is 
important for promoting overall health and functioning. 
Other research has started to investigate the relationship between sleep and HRQOL in 
youth with chronic illnesses. In a sample of adolescents with three chronic pain conditions 
(juvenile idiopathic arthritis, headache, and sickle cell disease), a range of sleep disturbances 
18 
 
 
were associated with decrements in HRQOL (Palermo & Kiska, 2005). Sleep disturbances 
showing robust associations with HRQOL included daytime sleepiness or fatigue and sleep/wake 
problems (e.g., irregular sleep habits, prolonged sleep latency, and difficulties getting up in the 
morning; Palermo & Kiska, 2005). This emerging body of research suggests the importance of 
including HRQOL as an outcome domain in pediatric sleep research and investigating the link 
between sleep and HRQOL in other chronic illness samples. 
Psychological Functioning in Youth with SB 
Prevalence rates of internalizing symptoms (i.e., depression, anxiety) rise dramatically in 
adolescence
 
(Garber, 2002), and likewise, youth with SB may have an elevated risk of 
internalizing symptoms during the adolescent period (Appleton, 1997; Essner & Holmbeck, 
2010) that extends into young adulthood (Bellin et al., 2010). Indeed, adolescent-onset 
depression has been associated with an increased risk for recurrent episodes of depression in 
adulthood (Graber, 2004), necessitating research on factors that contribute to internalizing 
symptoms in adolescents with SB. Further, children and adolescents with SB may have impaired 
physical and psychosocial HRQOL compared to TD and chronically ill pediatric populations 
(Cate, Kennedy & Stevenson, 2002; Murray, Holmbeck, Ros, Flores, Mir, & Varni, in press).  
Sleep and Family Functioning 
As is true of many of the links between sleep and bio-neuropsychosocial functioning 
discussed thus far, associations between sleep and family functioning are likely complex and 
reciprocal; a close, warm family environment may promote appraisal of safety and healthy sleep, 
and conversely, stress and conflict may lead to increased worry, rumination and disrupted sleep 
(Dahl & El-Sheikh, 2007). Just as conflict may disrupt sleep, child and adolescent sleep may also 
19 
 
 
impact the family environment (Meltzer & Westin, 2011). For example, adolescent sleep 
disturbances may increase the likelihood of emotional problems, thereby contributing to a more 
stressful and high-conflict home environment (Kelly & El-Sheikh, 2011). Cross-sectional work 
has supported relations between child and adolescent sleep disturbance and family functioning. 
El-Sheikh and colleagues (2006) found that decreased sleep quantity and quality as measured by 
actigraphy was associated with increased child-report of marital conflict. Congruent with this 
research, a study on Mexican-American adolescents found that self-reported sleep disturbances 
were associated with marital and parent-child conflict (McHale, Kim, Kan, & Updegraff, 2011). 
Longitudinal research has also indicated that disturbed sleep as measured by actigraphy predicted 
increases in marital conflict (Kelly & El-Sheikh, 2011). While research examining the potential 
impact of sleep on family functioning is in its infancy, available evidence suggests that family 
environment may be a highly relevant outcome of interest.   
Family Functioning in Youth with SB 
Research on family functioning in children and adolescents with SB has revealed variable 
results. Family relationships are particularly salient and influential social relationships for youth 
with SB, given that social isolation from peers is more common in this population than TD youth 
(Holmbeck et al, 2003). Generally, families of youth with SB may be at-risk for decreased levels 
of family cohesion, particularly those from lower socio-economic backgrounds (Holmbeck, 
Coakley, Hommeyer, Shapera, & Westhoven, 2002). Yet, research has also revealed similar 
levels of conflict in families of youth with SB compared to TD youth (Holmbeck et al., 2002) 
and, further, families of youth with SB do not evidence normative increases in family conflict as 
a function of pubertal development (Coakley, Holmbeck, Friedman, Greenley, & Thil, 2002). 
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These findings support a “resilience-disruption” view of family functioning (Costigan et al., 
1997); the experience of having a child with SB may disrupt some aspects of family functioning, 
yet these families still demonstrate considerable resilience on other adjustment domains. 
Families of youth with SB may be less cohesive while still experiencing lower levels of conflict. 
Sleep and Neuropsychological Functioning 
There is growing evidence that sleep disturbances and daytime sleepiness affects 
neuropsychological functions involving the prefrontal cortex (i.e., attention and executive 
function) in TD children and adolescents. The majority of literature on the neuropsychological 
consequences of sleep disturbances in children and adolescents has focused on the cognitive 
impact of experimental sleep restriction and deprivation (to induce subjective and physiological 
sleepiness) and sleep disorders (e.g., obstructive sleep apnea; Kheriandish & Gozel, 2006). This 
research has documented the association between sleep disturbances and a range of 
neuropsychological deficits, including attention, concentration, memory, and executive function 
(Kheriandish & Gozal, 2006). However, current studies have tended to focus on the 
neuropsychological impact of sleep disturbances on younger children, with much less attention 
paid to adolescent populations (Beebe et al., 2008). Attention and executive function are 
particularly important neuropsychological outcomes to study in adolescent populations; while 
disrupted sleep often manifests in young children as hyperactivity, inattention, and poor 
concentration, adolescents are more likely to exhibit symptoms of inattention and higher-order 
cognitive processes (i.e., executive dysfunction) than hyperactivity (O’Brien, 2013). It should be 
noted that executive function is a system of related constructs (i.e., planning, working memory, 
problem solving, inhibition, and mental flexibility) believed to be primarily located in the 
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prefrontal cortex (O’Brien, 2013). Further, prefrontal brain regions are believed to be particularly 
vulnerable to sleep deprivation (Dahl, 2002) and the prefrontal cortex may undergo a period of 
protracted development during adolescence (Blakemore & Choundury, 2006). Such cognitive 
vulnerability, coupled with the knowledge that adolescents often obtain inadequate sleep, 
necessitate further studies that examine the impact of sleep disturbances on neuropsychological 
outcomes in during the adolescent developmental period (Beebe et al., 2008).  
Overall, reduced sleep quantity as measured by experimental sleep restriction studies is 
associated with decrements in parent and teacher report of questionnaire-based inattention and 
executive dysfunction (Beebe et al., 2008; Fallone, Seifer, Acebo, & Carskadon, 2005; Moreau, 
Rouleau, & Morin, 2013), as well as behavioral inattention as measured by research assistants 
(Fallone, Acebo, Arnedt, Seifer, & Carskadon, 2001). Findings are variable for performance-
based measures of inattention, with some research suggesting a link between sleep quantity and 
quality and performance-based inattention (Gruber, Wiebe, Montecalvo, Brunetti, Amsel & 
Carrier, 2011; Sadeh, Gruber & Raviv, 2002) while others have found no such association 
(Fallone et al., 2001; Meijer, Habekothe, Van Den Wittenboer, 2000).  
Further, increased inattention and executive dysfunction has been documented in 
pediatric sleep disorders characterized by sleep fragmentation (i.e., increased night wakenings) 
and increased daytime sleepiness, including SDB, delayed sleep phrase syndrome, and restless 
legs syndrome (Beebe et al., 2004; Giannotti, Cortesi, Sebastiani, & Ottaviano, 2002; Blunden, 
Lushington, Kennedy, Martin, & Dawson, 2000; Cortese et al., 2005). For example, children 
with mild SDB demonstrated diminished performance-based selective and sustained attention 
compared to controls (Blunden et al., 2000). Researchers have even suggested the presence of a 
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dose-dependent response in attention scales, such that children with moderate to severe OSA 
show greater attention deficits (Owens-Stively et al., 1997). Further, viewing the association 
between sleep and inattention from a developmental psychopathology perspective, sleep 
disturbances and daytime sleepiness are also common in children and adolescents with ADHD 
(Chervin, Dillon, Bassetti, Ganoczy, & Pituch, 1997; Cortese, Konofal, Yateman, Mouren, & 
Lecendreaux, 2006; Gau & Chiang, 2009); an estimated 25 to 50% of children and adolescents 
with ADHD have difficulties initiating and maintaining sleep (Corkum, Tannock & Moldofsky, 
1998). Researchers have speculated that youth with ADHD may have intrinsic factors associated 
with sleep problems, including a hyper-arousal mechanism preventing or delaying sleep onset
 
(Dahl, 1999).  
Neuropsychological Functioning in Youth with SB 
Due in part to brain malformations characteristic of SB and the consequences of shunt 
placement at birth (i.e., shunt infections and replacement), the majority of youth with SB have 
mild to moderate neuropsychological impairments, such as executive dysfunction, inattention, 
and impaired intellectual functioning (Rose & Holmbeck, 2007). Youth with SB tend to exhibit 
attention problems that are similar to children with attention-deficit/hyperactivity disorder 
ADHD- inattentive type (e.g., high distractibility, poor organization of materials, and difficulty 
staying on task), and have higher rates of ADHD compared to their TD peers (Burmeister et al., 
2005). Burmeister and colleagues (2005) reported a 31% prevalence rate of ADHD among youth 
with SB (the majority of whom were the inattentive type), compared to 17% of TD peers. 
However, there are distinct differences between the manifestation of attention problems in youth 
with SB compared to those with ADHD; children with SB show greater difficulty with posterior 
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brain attention processes, rather than the anterior attention deficits that are commonly associated 
with ADHD (Brewer, Fletcher, Hiscock, & Davidson, 2001). The anterior brain attentional 
system is related to sustaining and maintenance functions of attention, whereas the posterior 
system mediates attention functions related to focusing and shifting. In particular, youth with SB 
typically have difficulties with orienting to important information, focusing, and shifting 
attention
 
(Dennis, Landry, Barnes, & Fletcher, 2006; Brewer et al., 2001; Rose & Holmbeck, 
2007) but not sustained attention. Therefore, a child with ADHD may showcase more classic 
clinical symptoms of this disorder, such as difficulty attending to verbal and visual stimuli. In 
contrast, a child with SB may be able to attend to exogenous information, yet will require more 
time to disengage, shift, and orient to another stimulus. 
Moreover, there are strong and consistent data to support the commonality of executive 
function deficits in youth with SB, which may include difficulties in the areas of cognitive 
flexibility, abstract reasoning, visual planning, sequencing, and switching (Burmeister et al., 
2005; Fletcher et al., 1996; Hampton et al., 2011; Rose & Holmbeck, 2007; Snow, 1999; 
Tuminello et al., 2012) as well metacognitive tasks (i.e., task initiation, working memory, 
planning, organization, and self-monitoring; Brown et al., 2008; Zabel et al., 2011). Although 
executive function skills are believed to be controlled by frontal brain regions (Anderson, 1998), 
executive dysfunction in individuals with SB may be explained by anomalies in posterior and 
other brain areas (e.g., the cerebellum). In fact, the measurement of executive function is often 
complicated because other neuropsychological constructs that are known to be weaker in this 
population are implicated, including posterior attention system- mediated attentional shifting 
skills, as well as fine motor skills controlled by the cerebellum (Burmeister et al., 2005).  
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Further, it has been hypothesized that the under-arousal and disengagement in problem solving 
tasks typically seen in this population may be due to posterior controlled arousal-activation 
system. Yet, to date, the neurological origins of executive function skills in this population are 
not fully understood.  
Sleep and Academic Functioning 
Intricately related to neuropsychological functioning, research demonstrates that learning 
capacity and school performance (e.g., lower grades; Beebe, Rose, & Amin, 2010; Curcio, 
Ferrara, De Gannaro, 2006; Fallone, Owens & Deane, 2002; Wolfson & Carskadon, 2003) may 
be significantly impacted by poor sleep, increased sleep fragmentation, and late bedtimes and 
early awakenings (e.g., shortened sleep time). A recent meta-analysis found that three sleep 
domains (sleep quantity, sleep quality, and daytime sleepiness) had small but significant effects 
on children and adolescents’ school performance (Dewald, Meijer, Oort, Kerkhof, & Bogels, 
2010). Effect sizes were larger for daytime sleepiness and smaller for sleep quantity; smaller 
effects of sleep quantity may be due to each individual’s differential sleep need and individual 
vulnerability to sleep loss (Dewald et al., 2010). While the neural mechanisms of the impact of 
sleep on neuropsychological performance are unclear, researchers have posited that short or 
disrupted sleep may reduce overnight brain activation that is necessary for optimal 
neuropsychological functioning; insufficient or poor quality sleep in adolescence may increase 
daytime sleepiness (thereby decreasing alertness) and impair executive function of the PFC, and 
consequently, learning capacity and school performance (Dewald et al., 2010).  
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Academic Functioning in Youth with SB 
Finally, given that neuropsychological deficits are common in this population, it 
unsurprising that children with SB also have difficulties in certain academic areas, including 
arithmetic, reading comprehension, and spelling (see Wills, 1993 for a review). Holmbeck and 
colleagues (2003) found that preadolescents with SB, and particularly those from low SES 
homes, scored lower on measures of scholastic competence, several teacher-reported indicators 
of academic performance (e.g., school grades), and parent report of future educational aspirations 
compared to their TD peers. Such cognitive and academic struggles may also impact 
achievement of academic milestones, as emerging adults with SB report lower college 
attendance compared to their peers (41% vs 70%; Zukerman Devine, & Holmbeck, 2011) 
The Current Study and Hypotheses 
Despite emerging evidence of the prevalence and impact of sleep disturbances in 
pediatric populations, there are very few studies that have assessed sleep in youth with SB. 
Multi-method studies that comprehensively assess sleep-wake disturbances using objective and 
subjective sleep instruments are essential for characterizing the nature of these problems. The 
proposed research bridged a critical gap in knowledge by assessing sleep-wake disturbances in 
adolescents with SB, and examining the impact of sleep on adolescents’ physical, psychological, 
family, and neuropsychological functioning (Figures 2 & 3). Sleep represents an important 
modifiable behavioral domain for diagnosis and intervention, and several researchers have 
advocated for behavioral sleep interventions to improve adolescent functioning (e.g., mood and 
attention symptoms; Dahl & Harvey, 2007; Mindell, Kuhn, Lewin, Meltzer & Sadeh, 2006; 
Gordon, King, Gullone, Muris, & Ollendick, 2007). Further, targeted interventions in childhood 
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and adolescence are particularly important due to the potential impact of sleep disturbances on 
emotional and cognitive development across the lifespan
 
(Gregory, Caspi, Eley, Moffitt & 
O’Connor, 2005; Gregory & O’Connor, 2002; Johnson, Chilcoat, & Breslau, 2000). Knowledge 
gained from this study informs the development of treatments designed to improve overall health 
and well-being in adolescents with SB. 
Part one (addressing Hypotheses 1-3) of this project is a two-group study design utilizing 
a comprehensive sleep assessment including objective (actigraphy) and subjective (questionnaire 
and daily diary) measures. The two matched groups include: (1) adolescents with SB, and (2) 
typically developing (TD) peers. Specifically, we plan to use a matched comparison group 
recruited from a separate NIH-funded study to assess group differences in sleep-wake 
disturbances. Part two (addressing Hypothesis 4) of this project assessed the impact of sleep-
wake disturbances on bio-neuropsychosocial functioning in the SB group only. Primary outcome 
variables include Body Mass Index (BMI), pain, internalizing symptoms, health-related quality 
of life (HRQOL), family functioning, inattention/hyperactivity, executive function, and academic 
functioning.   
Hypothesis 1 
Subjective survey measures will indicate that adolescents with SB have worse sleep 
quality and sleep habits, greater pre-sleep arousal, increased problems with fatigue, and more 
symptoms of insomnia as compared to TD adolescents. Further, utilizing actigraphic recordings, 
adolescents with SB will demonstrate reduced sleep efficiency, shorter total sleep time, more 
time awake after sleep onset (i.e., nighttime awakenings), and longer daytime naps compared to 
TD adolescents.  
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Hypothesis 2 (Figure 2) 
Daily diary and actigraphic measures will indicate that poorer sleep quality and greater 
sleep fragmentation (reduced sleep efficiency, shorter total sleep time, and more nighttime 
awakenings) will predict worse pain and mood the following day. The chronic physical, medical, 
cognitive, and social demands of a complex medical illness such as SB may impede youths’ 
ability to cope with poor sleep quality, painful symptoms, and negative mood. Thus, it is likely 
that such symptoms will have a significant impact on daytime functioning for adolescents with 
SB in particular; in other words, it is expected that temporal associations between sleep quality, 
pain, and mood will be stronger for adolescents with SB as compared to TD adolescents. 
Hypothesis 3 (Figure 2) 
Conversely, daily diary and actigraphic measures will indicate that higher pain intensity 
and poorer daytime mood will predict worse nighttime sleep quality and greater sleep 
fragmentation. Similar to hypothesis 2, it is expected that associations will be stronger for 
adolescents with SB compared to TD adolescents.  
Hypothesis 4 (Figure 3) 
Greater sleep-wake disturbances will be associated with higher Body Mass Index (BMI) 
and greater pain (intensity and frequency), internalizing symptoms, family conflict, 
inattention/hyperactivity, and executive dysfunction in adolescents with SB. It is also expected 
that greater sleep-wake disturbances will be associated with lower health-related quality of life 
(HRQOL), family cohesion, and academic functioning (lower scholastic competence and school 
grades) in this population.  
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METHODS 
Participants and Recruitment 
This project included 74 adolescents and their parents, ages 12-18: (1) adolescents with 
SB (SB group; N = 37) and (2) typically developing peers (TD group; N = 37). Specific details 
regarding each group are outlined below.  
SB Group 
The sample of adolescents with SB were recruited from a pool of adolescents 
participating in a longitudinal NIH-funded research study led by Grayson Holmbeck, PhD: 
Chicago Healthy Adolescents Transition Study (CHATS). The overarching aim of the CHATS 
study is to assess family, peer relations, neuropsychological correlates, and psychological 
adjustment outcomes in youth as they progress from childhood to young adulthood. The 
subsample used for the current study were drawn from participants entering their third, fourth, or 
fifth data collection waves of the CHATS study. Inclusion criteria for the subsample were: 1) 
diagnosis of SB, including myelomeningocele, lipomeningocele, or myelocystocele; 2) 12 to 18 
years of age; 3) proficiency in English or Spanish; 4) involvement of at least one parent; 5) 
cognitive ability to complete questionnaires; and 6) residence within 300 miles of the laboratory 
to allow for home visits. Participants in the SB group were matched across several demographic 
variables to the TD Group (see below for further details). The proposed project was integrated 
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into the CHATS study by adding a 10-day objective and subjective sleep assessment for 40 
youth with SB meeting the above criteria. This study used measures of height/weight (to 
calculate BMI), pain, internalizing symptoms, HRQOL, family conflict and cohesion, 
inattention/hyperactivity, executive function, and academic performance that were already part 
of CHATS study procedures. During a regularly scheduled home visit, qualified youth were 
informed that a sleep study was added to the larger study and were invited to participate. Youth 
assent and parent consent was added to the study assent and consent forms under an “Additional 
Studies” section in which youth and parents mark “yes” or “no” to study participation. IRB-
approval from Lurie Children’s Hospital and Loyola University Chicago was received for 
modifications of study procedures and consent forms. Participants received $50 for participating 
in the optional 10-day sleep assessment. Further, consent from families was provided for health 
professionals and research assistants to conduct medical chart reviews for adolescents in the SB 
group.  
 A total of 51 eligible participants were invited to participate between October 2012 and 
July 2015. Of the 51 families, 9 participants declined to participate in the sleep assessment 
portion of the study due to lack of interest or time constraints and 5 declined from the larger, 
longitudinal study. Thus, the total analyzed cohort included 37 adolescents with SB. Adolescents 
who declined (N = 14) participation did not differ from those who accepted participation (N = 
37) with respect to age (t[49] = 1.69, p = .10), sex (χ2 [1] = .01, p = .98), race (Caucasian vs. 
other; χ2 [1] = .35, p = .55) ethnicity (Hispanic vs. non-Hispanic; χ2 [1] = .27, p = .60), type of 
SB (e.g. myelomeningocele or other; χ2 [1] = .01, p = .91), or shunt status (χ2 [1] = .61, p =. 44)  
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TD Group 
The TD comparison group were recruited from an existing NIH-funded study, conducted 
by Dr. Tonya Palermo. The comparison sample was recruited as part of Dr. Palermo’s larger, 
longitudinal study (one year in length with three data collection waves) comparing sleep-wake 
disturbances in adolescents with and without chronic pain (Palermo, Law, Churchill, & Walker, 
2012); sleep assessment data collection procedures for this sample are complete. The cohort of 
typically developing adolescents (without chronic pain) were recruited in the Pacific Northwest 
via community advertisements. Inclusion criteria were: 1) 12 to 18 years of age; 2) proficiency in 
English; 3) absence of a serious co-morbid health condition (e.g., cancer, diabetes) or 
documented development delay; and 4) no current parent-reported psychiatric diagnoses. 
Participants in Dr. Palermo’s study received $50 for completing study procedures. Children of 
families from the TD group who declined participation did not differ from those who accepted 
participation with respect to age and gender (Palermo et al., 2011). An initial pool of 78 
adolescents between the ages of 12-18 were available to facilitate matching procedures.  
Matching Procedures 
Adolescents in the SB group who agreed to participate in the sleep study were matched to 
the initial TD sample. Participants were matched utilizing a case-by-case sorting process, 
prioritizing the following sociodemographic variables: age, gender, ethnicity, and income level. 
A balanced selection approach was utilized; for example, when the best match for a 14-year-old 
Hispanic female with SB was a typically-developing 14-year-old Hispanic female with a higher 
family income, the next match was selected to correct the imbalance- i.e., a youth with SB that 
31 
 
 
has higher family income was paired with a TD youth that has a lower family income. See below 
(pg. 53 and Table 2) for results of matching procedures.  
Procedures 
The SB group completed actigraphic and subjective sleep procedures identical to those 
utilized in Dr. Palermo’s study to ensure compatible comparison data. Parents and youth 
completed informed consent forms and subjective sleep measures (outlined below) which were 
added to existing study questionnaire packets. Participants received instruction in using the 
Actiwatch 64 (AW64) and completion of paper diaries. As previous research indicates that at 
least five nights of actigraphy recording are necessary to obtain reliable sleep measures (Acebo 
et al., 1999), participants in this study were asked to wear the Actiwatch for ten consecutive days 
to ensure participants wore the watch for at least five nights total. Actiwatch and paper diaries 
were mailed back to study staff using pre-paid envelopes, and periodic follow-up phone calls 
helped to ensure compliance. Dr. Tonya Palermo (project consultant) provided actigraphy 
equipment (including watches, hardware, and software) necessary for actigraphic assessment and 
coding procedures.  
Measures 
Demographic Information 
Parents completed a demographics form to assess child’s age, gender, ethnicity, race, as 
well as parent education, occupation, family annual income, and family structure.  
Spina Bifida Medical Information 
Medical records were reviewed to gather the following SB medical information: type of 
SB (i.e., myelomeningocele, meningocele, or lipomeningocele), shunt status, and lesion level. 
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For this study, we analyzed lesion level as a continuous variable. Specifically, participants were 
assigned a score that ranged from 1 to 14, with lower numbers representing lower-level lesion. A 
score of ‘1’ represented a lesion in the S3 region (the lowest lesion level among the group) 
whereas a score of ‘13’ represented a T7 lesion (the highest lesion level among the group). In the 
absence of chart data, parent-report was used to assess type of SB (91.9% of data derived from 
chart review, 8.1% parent report) and shunt status (83.8% chart review, 16.2% parent report).  
Parents of youth with SB completed a medical form to collect additional medical 
information on their child’s current prescription medications, number of shunt revisions (since 
birth), number of surgeries and hospitalizations (in the previous two years), and current gross 
motor functioning. Prescription medication information was re-coded to create a summary 
variable indicating the total number of different prescription medication types taken by each 
participant. For example, a participant taking an antidepressant and antispasmodic would be 
coded as having two prescription medication types total. To assess gross motor functioning, we 
utilized a modified version of The Gross Motor Function Classification System Expanded and 
Revised (GMFCS-E&R) developed by Palisano, Rosenbaum, Bartlett, & Livingston (2007). 
Specifically, we gathered information from mother-report on a Medical History Questionnaire 
(or father-report in the absence of mother data) to assign participants a gross motor classification 
scale level based on the GMFCS-E&R: Level I: No braces, crutches, walker, or wheelchair (i.e., 
100% unassisted walking), Level II: Uses braces, crutches, or walker, Level II: Some wheelchair 
use, but able to walk with braces (> 50% walking), and Level IV: Uses wheelchair at school 
and/or long outings, may walk for short distances with a walker  (< 50% walking). 
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Finally, The Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) from 
the first data collection wave was used as a proxy for general intellectual functioning. The WASI 
includes tasks within the performance and verbal domains, and is frequently utilized to provide 
an intelligence quotient (IQ). Specifically, the Vocabulary and Matrix Reasoning subtests were 
administered to participants in the present study to obtain an estimate of IQ. The Vocabulary 
subtest is a 42-item measure that assesses for expressive vocabulary, verbal knowledge, and fund 
of information. In addition, it is a reliable measure of crystallized intelligence and general 
intelligence (e.g., Wechsler, 1999). On items one through four, the examinee is required to name 
pictures (e.g., bucket). On items five through 42, words are orally and visually presented, and the 
examinee is required to provide a definition (e.g., what is a car?). The Matrix Reasoning subtest 
assesses nonverbal abstract problem solving, inductive reasoning, and spatial reasoning skills. In 
addition, it has been found to be a reliable and valid measure of fluid intelligence, correlating .81 
with another common measure of fluid intelligence (Wechsler, 1999). Matrix Reasoning consists 
of 35-items, each consisting of an incomplete pattern. The examinee is asked to complete the 
pattern by selecting the best choice from five options. In general, higher scores on these 
measures represent higher levels of intellectual abilities. Standardized norms for both of these 
subtests have been obtained across 2,245 individuals aged six through 89, and average test-retest 
reliability coefficients of .89 (Vocabulary) and .92 (Matrix Reasoning) were obtained for 
children 6 to 16 years old (Wechsler, 1999).  
Pubertal Status 
Parent report of pubertal status was measured with the Pubertal Development Scale 
(PDS; Petersen, Crockett, Richards, & Boxer, 1988). Responses on the PDS range from 1 to 4 
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and were scored and categorized such that higher scores indicated more advanced pubertal status. 
For the SB and TD samples, internal consistency was adequate for boys (SB:  = .90; TD:  = 
.74) and slightly lower for girls (SB:  = .66; TD:  = .71).  
Objective and Subjective Sleep-Wake Variables 
 An objective and subjective sleep assessment was conducted for this study; ambulatory 
actigraphic recordings was completed over 10 days, and adolescents completed a daily diary and 
several sleep questionnaires. Table 1 displays all sleep variables by measurement category.   
Objective Sleep Variables (Actigraphy Monitoring) 
The Actiwatch 64 (AW64; Phillips Respironics) was used to assess sleep patterns. The 
small, lightweight actiwatch is a wristwatch-like device that records sleep-wake patterns by 
monitoring movement (or lack of movement) during the daytime and nighttime (See Figure 4).  
Movement is “sensed” by an omni-directional mercury switch that opens when movement is 
detected. The AW64 is not recommended for diagnosis of physiological sleep disorders (e.g., 
sleep disordered breathing); however, it is considered a highly effective, reliable, and 
unobtrusive tool for examining day-to-day variation in sleep quality and quantity, with 85-95% 
agreement rates with polysomnographic sleep studies (Gruber & Sadeh, 2004). Actigraphy data 
was stored and scored using computer software (Actiware 5.0; Webster, Kripke, Messin, 
Mullaney, & Wyborney, 1982) and a manualized coding procedure. Dairies (see below) were 
also used as a tool to facilitate coding of actigraphic sleep patterns, such as to confirm whether a 
period of inactivity/low activity is due to a participant removing the actiwatch or taking a nap 
during the daytime.  
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Table 1. Sleep-Wake Variable Definitions  
Sleep-Wake 
Variables 
Definition 
Actigraphy  
Total Sleep Time Sleep quantity, or time spent sleeping between sleep onset and offset (reported in 
minutes or hours) 
Wake After Sleep 
Onset (WASO) 
Number of minutes scored as awake between sleep onset and sleep offset  
Sleep Efficiency [Total sleep time  time in bed] x 100 (expressed as a percent) 
Sleep Variability Variability in total sleep time (SD of total sleep time/ total number of nights) for each 
individual 
Nap Duration Number of minutes spent sleeping during the daytime (predetermined minimum nap 
duration ≥15 min) 
Diary Report  
Sleep Quality Daily self-report of sleep quality (0 = extremely poor to 10 = extremely good) derived 
from paper diary 
Questionnaire Report 
Sleep Quality
 
 Self-reported sleep quality, derived from total score and subscales
 
of the ASWS
a 
Insomnia 
Symptoms  
Self-reported difficulty falling asleep and/or maintaining sleep 60% or more of the time 
(2 items of ASWS)  
Pre-sleep Arousal Self-reported arousal before sleep onset, derived from total score and subscales
b 
of the 
PSAS 
Sleep Habits Self-reported sleep-facilitating or –inhibiting practices, derived from total score and 
subscales of the ASHS
c 
Sleep-Disordered 
Breathing 
Parent-reported symptoms of sleep-disordered breathing. Total score ≥ 0.33 on PSQd 
suggestive of SDB
 
  Fatigue Self-reported daytime fatigue, derived from total score and subscales of the PedsQL-
MFS
e
 
a
The ASWS (Adolescent Sleep Wake Scale) includes a total sleep quality score as well as 5 
subscales: going to bed, falling asleep, maintaining sleep, reinitiating sleep, and returning to 
wakefulness. 
b
The PSAS (Pre-sleep Arousal Scale) includes a total pre-sleep arousal score as well as 2 
subscales: cognitive and somatic arousal. 
c 
The ASHS (Adolescent Sleep Hygiene Scale) includes a total sleep habits score and 6 subscales 
(physiological, cognitive, emotional, sleep environment, substances, and sleep stability. The 
physiological and subscales subscales were not included in this study due to low reliability. 
d 
The PSQ (Pediatric Sleep Questionnaire) was administered to the SB group only and includes a 
total score and three subscales: daytime sleepiness, snoring, and problem behaviors. The current 
study used the total score to provide descriptive data on symptoms of sleep-disordered breathing 
(SDB) and the snoring and daytime sleepiness subscales in multivariate analyses (i.e., 
Hypothesis 4). 
e
The PedsQL-MFS (PedsQL Multidimensional Fatigue scale) includes a total score and three 
subscales: general, sleep/wake, and cognitive fatigue. Higher scores indicating less difficulties 
with fatigue. 
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Figure 4. Actigraphy Recording Example 
 
Utilizing these scoring methods, the following sleep parameters were obtained: (1) total 
sleep time, or duration of time spent sleeping while in bed; (3) wake after sleep onset (WASO), 
or the total number of minutes scored as awake during total sleep time period; (4) sleep 
efficiency, or the ratio of estimated total sleep time and time in bed expressed as a percent ([total 
sleep time  time in bed] x 100) with values closer to 100 representing good sleep efficiency; 
and (5) nap duration or number of minutes spent sleeping during the daytime. Further, to assess 
night-to-night variation in sleep patterns we also calculated (6) sleep variability or the variability 
in total sleep time, by computing the standard deviation in total sleep time over the total number 
of nights for each individual. 
 The study investigator coded the length of daytime naps (average of all naps in minutes, 
minimum nap duration of 15 minutes) by assessing participant actigraphy data and using daily 
diaries for verification and validation.  Nap data was coded if present in noted in the daily diary 
and confirmed using daytime actigraphy records. Actigraphy has been shown to be a valid sleep 
assessment tool in youth and adults with severe neurological disorders and mild mobility 
impairments (Scheer, Zeitzer, Ayas, Brown, Czeisler, & Shea, 2005; Zollman, Cyborski, & 
Duraski, 2010). As recommended by researchers utilizing actigraphy in individuals with lower 
limb mobility impairments (Zollman, Cyborski, & Duraski, 2010), the actigraph was worn on the 
wrist or upper arm to ensure valid actigraphic data collection. The graduate student investigator 
scored all actigraphy data using manualized coding procedures. 
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Subjective Sleep-Wake Variables 
Sleep Quality 
Diary-reported sleep quality and diary assessment procedures. The 10-day diary was 
used to assist with actigraphy coding procedures and assess the adolescent’s daily subjective 
perception of sleep quality, as well as mood and pain level. Each morning, participants answered 
questions pertaining to: quality of sleep the previous night (Likert scale; 0 = extremely poor to 10 
= extremely good), mood (Likert scale; 0 = extremely poor to 10 = extremely good), as well as 
bedtime/wake time, sleep latency, and number and duration night awakenings. Each evening, 
participants reported on pain intensity (Likert scale; 0 = No pain at all to 10 = Worse pain), 
daytime napping, and if/when the actiwatch was removed. Daily perception of sleep quality, 
mood, and pain were only included in HLM analyses testing temporal associations between 
sleep, mood, and pain (i.e., Hypotheses 2 and 3).  
Questionnaire-reported sleep quality. Adolescents completed the Adolescent Sleep 
Wake Scale (ASWS; LeBourgeois et al., 2005). The ASWS is a 32-item self-report scale that 
assesses self-perceived quality of sleep across five behavioral dimensions: going to bed, falling 
asleep, maintaining sleep, reinitiating sleep, and returning to wakefulness. Items assess the 
occurrence and frequencies of these sleep behaviors in the past month along a 6-point scale (1 = 
never to 6 = always). The ASWS has demonstrated adequate internal validity and consistency in 
adolescents (LeBourgeois et al., 2005). Higher scores on the ASWS represent better sleep 
quality. In the current sample, internal consistency was adequate for the total scale (SB:  = .84; 
TD:  = .83) and majority of the subscales (SB: s = .62- .72; TD:  = .64-.78). Internal 
consistency for the Falling Asleep subscale was inadequate for the SB group ( = .56, TD group: 
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 = .74), thus one item (“When it’s time to go to sleep, I feel sleepy”) was dropped to improve 
reliability (SB:  = .66; TD:  = .79).  
Insomnia Symptoms 
Insomnia symptoms were evaluated using two items from the ASWS (described above) 
assessing difficulty falling asleep (i.e., “I have trouble going to sleep” item from the falling 
asleep subscale) and difficulty maintaining sleep (i.e., “After waking up during the night, I have 
trouble going back to sleep” item from the reinitiating sleep subscale). Adolescents who 
responded “quite often,” “frequently, if not always,” or “always” (i.e., 60% of the time or more 
often) to either of these items were judged to have symptoms of insomnia. Previous research has 
used similar methods to assess for insomnia symptoms in adolescents (Palermo et al., 2011).  
Pre-Sleep Arousal 
Adolescents reported on pre-sleep arousal using the 16-item Pre-Sleep Arousal Scale 
(PSAS; Nicassio, Mendlowitz, Fussell, & Petras, 1985), which measures somatic (e.g., tense 
muscles, pounding heart) and cognitive arousal (e.g., heart palpitations, racing thoughts) prior to 
sleep onset during a typical week. Respondents rate the presence and intensity of these 
symptoms using a 5-point scale (1 = not at all to 5 = extremely). Higher scores on the PSAS 
indicate greater arousal before falling asleep. In the current sample, internal consistency was 
adequate for the somatic subscale (SB: = .93; TD:  = .85), cognitive subscale (SB: = .91; 
TD:  = .83), and total scale (SB: =.91; TD:  = .83).  
Sleep Habits 
Sleep habits were measured with the Adolescent Sleep Hygiene Scale (ASHS; 
LeBourgeois et al., 2005). The ASHS is a 24-item self-report scale that assesses sleep-facilitating 
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and sleep-inhibiting habits or practices across six conceptual dimensions: physiological, 
cognitive, emotional, sleep environment, substances (e.g., caffeine), and sleep stability. Items are 
scored on a 6-point scale (1 = always to 6 = never), with higher scores indicating better sleep 
habits. Internal consistency was also adequate for the total scale (SB: =.87; TD:  = .82) and 
the emotional (SB: =.85; TD:  = .78) and sleep environment subscales (SB: =.69; TD:  = 
.78) of this measure. Reliability was inadequate for the TD group on the cognitive ( = .50) and 
sleep stability subscales ( = .58). Dropping one item on the cognitive subscale (“I use my bed 
for things other than sleep, for example, talking on the phone…”) and one item on the sleep 
stability subscale (“During the school week, I ‘sleep in’ more than one hour past my usual wake 
time”) improved reliability (s = .62 & .67, respectively). Internal consistency was inadequate 
for both groups on the physiological subscale (SB: =.42; TD:  = .55), yet dropping items from 
the physiological subscale did not improve internal consistency. Further, both items on the 
substances scale had very little variance because the majority of adolescents (97.2%) endorsed 
never using alcohol or tobacco in the evening. Thus, the physiological and substance subscales 
were not included in study analyses.  
Fatigue 
Fatigue was assessed via adolescent self-report with the PedsQL Multidimensional 
Fatigue scale (PedsQL-MFS; Varni et al., 2004). This is an 18-item scale designed to assess the 
presence and severity of fatigue over the past month along three domains: general fatigue, 
sleep/rest fatigue, and cognitive fatigue. Much like the PedsQL Generic Scale, responses on the 
PesdQL-FS are on a five-point scale (0 = never to 4 = almost always). Items are reverse-scored 
and linearly transformed to a 0-100 scale, with higher scores indicating less difficulties with 
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fatigue. In the current study, internal consistency was adequate for the subscales (SB: =.77- .87; 
TD:  = .69-.83) and total scale (SB: =.91; TD:  = .81) of this measure.  
Sleep Disordered Breathing and Daytime Sleepiness 
For the SB group only, one caregiver completed the 22-item sleep disordered breathing 
scale of the Pediatric Sleep Questionnaire (PSQ; Chervin et al., 2000). The PSQ is frequently 
used in sleep clinics to assess symptoms of sleep-disordered breathing and related symptoms 
when polysomnography is not feasible, and has demonstrated adequate reliability and validity 
(Chervin et al., 2000). The 22-item total score is a composite scale that assesses symptoms of 
sleep-disordered breathing and also contains subscale items specifically related to snoring (4 
items; e.g., “Does your child snore more than half the time?”), daytime sleepiness (4 items; e.g., 
“Does your child wake up feeling unrefreshed in the morning?”), and problem behaviors (6 
items; e.g., “Interrupts or intrudes on others”) that can be a manifestation of a sleep disorder.  
We utilized the total score of this measure to provide descriptive data on symptoms of 
sleep-disordered breathing (SDB) due to the high incidence of this disorder. SDB scores are 
calculated as the proportion of symptoms present; a score of 0.33 or greater has been determined 
to be suggestive of SDB (i.e., 33% of 22 questions or more answered positivity; Chervin et al., 
2000). We also chose to utilize the snoring and sleepiness subscales of the PSQ as predictor 
variables in multivariate analyses (to test Hypothesis 4) instead of the total score of the PSQ, 
which contains several items that overlap with the study’s outcome measures including BMI 
(i.e., “Is your child overweight”?) and inattention (“This child is often easily distracted by 
extraneous stimuli”). Internal consistency was adequate for the total Sleep Disordered Breathing 
score ( = .71) and Sleepiness subscale ( = .65). Internal consistency of the 4-item Snoring 
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subscale was inadequate ( = .45), thus one item (“While sleeping, does your child have ‘heavy’ 
or loud breathing?”) was dropped to improve reliability ( = .71).   
Bio-neuropsychosocial Outcome Variables (SB Group Only) 
 Diary-reported mood and pain level (see above) were the only two bio-neuropsychosocial 
variables collected for the TD and SB samples to test Hypotheses 2 & 3 utilizing HLM analyses. 
The following bio-neuropsychosocial variables were collected in the SB group only in 
multivariate analyses testing sleep-wake variables as predictors of bio-neuropsychosocial 
outcomes (Hypothesis 4).  
Forming Composite Measures 
Study investigators created composites that included multiple reporters of bio-
neuropsychosocial outcomes, which has been recommended as a useful multisource data 
management technique to decrease the number of analyses and reduce the possibility of shared 
method variance (Holmbeck et al., 2002). Pearson correlations were run for measures with two 
or more reporters (e.g., mother-, father-, teacher-, child-report) to assess associations between 
reporters of the same construct. Reports were averaged to create composite scores if at least 
moderately correlated (rs > .40).  
Body Mass Index (BMI) 
Weight status was measured using Body Mass Index (BMI) z-scores. BMI is obtained by 
dividing the child’s weight from his or her height squared (i.e., kg/m2). A BMI z-score was then 
computed based on tables published in 2000 by the U.S. Centers for Disease and Control 
Prevention. BMI z-scores take into account developmental changes in body composition as well 
as variations by age and gender (Kuczmarski et al., 2002). Height and weight was obtained 
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through chart review, or parents’ written estimates of their child’s height and weight when chart 
data was unavailable. 
Pain 
The current study assessed youths’ report of pain intensity and frequency over the last 
three months. Pain intensity was rated using a Visual Analogue Scale (VAS), which has 
demonstrated adequate reliability and validity in children and adolescents (Cohen et al., 2008). 
Participants marked the point along a 10-cm line that most accurately represented their pain 
severity, with anchors ranging from “no pain” to “worst pain ever.” Scores were calculated by 
measuring the distance from the lower end point of the scale to the mark made by the child. Pain 
frequency was rated on a 6-point Likert scale rating (0 = less than once per month to 5 = daily). 
Similar assessment of pain frequency has been utilized in previous research (e.g., Palermo, 
Valenzuela, & Stork, 2004).  
Internalizing Symptoms 
Parent and teacher responses to items on the Internalizing scale of the CBCL (Achenbach 
& Rescorla, 2001) were used to assess adults’ perceptions of child internalizing symptoms. 
Additionally, adolescents reported internalizing symptoms using the Child Depression Inventory 
(CDI), a 27-item self-rated measure of depressive symptoms. Two items from the CDI that 
pertain to sleep (“I have trouble sleeping” and “I am tired”) were dropped to reduce overlap 
between the sleep-wake variables and CDI scores. The CDI has been well validated in general 
populations, and has demonstrated adequate reliability in the current sample of adolescents with 
SB ( = .85). Mother- and father-reports of internalizing were significantly correlated (r = .45) 
and averaged together to form a composite score. Child and teacher report internalizing scores 
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were not correlated with any other reporter (rs = .02 - .31). Thus, we separately examined parent, 
teacher, and child report of internalizing.   
Health-related Quality of Life 
Youths’ HRQOL was assessed using youth, mother, and father report on the Pediatric 
Quality of Life Scale (PedsQL™ 4.0 Generic Core Scales; Varni, Seid, & Kurtin, 2001). The 
PedsQL has well-established reliability and validity in children with both acute and chronic 
health conditions, and yields an 8-item physical scale and 15-item psychosocial scale. The 
psychosocial scale is comprised of three subscales: emotional (5 items), social (5 items), and 
school functioning (5 items). Youth and parents answered how much of a problem a given task 
had been over the past month using a 5-point Likert scale rating (0 = never a problem to 4 = 
almost always a problem). Raw scores were reverse-scored and transformed into standard scores 
that ranged from 0 to 100, with higher scores indicating better HRQOL. The proposed study used 
adolescent and parent-report of the psychosocial HRQOL total scale, which demonstrated 
adequate reliability in the current sample across reporters (s= .85- .89). One item (“I have 
trouble sleeping”) from the PedsQL emotional subscale was dropped to reduce overlap between 
sleep variables and this subscale. The physical HRQOL scale of the PedsQL was not utilized in 
the current study as it contains items that may not be appropriate for youth with physical 
disabilities (e.g., “It is hard for me to run”; Oddson et al., 2006).  Mother, father, and child 
reports of HRQOL were averaged given significant correlations between reporters d (rs = .43 - 
.53).  
Family Functioning 
The Family Environment Scale (FES; Moos & Moos, 1994) measures social and 
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environmental characteristics of the family and is completed by parents. The current study used 
Form R, which measures people’s perceptions of their family environment. The FES includes 
three main dimensions (Relationship, Personal Growth, System Maintenance) comprising a total 
of ten subscales. For the purpose of this study, the cohesion and conflict subscales from the 
Relationship dimension were utilized. Examples of items on each subscale include: “there is a 
feeling of togetherness in our family” and “we fight a lot in our family,” respectively. Because 
internal consistency has been low in some studies using the original true-false response format 
(Alderfer et al., 2008), this study used a four-point Likert-type scale to increase internal 
consistency and gather richer data about the family environment (1 = strongly disagree to 4 = 
strongly agree). Reliabilities for mother and father report on the conflict and cohesion subscales 
were adequate (s= .71 - .83, respectively). Mean scores for mother and father reports of conflict 
and cohesion were averaged to create composite scores due to adequate correlations between 
reporters (conflict: r = .64; cohesion: r = .51). 
Inattention/hyperactivity 
The Swanson, Nolan, and Pelham Teacher and Parent Rating Scale version IV (SNAP-
IV; Swanson et al., 2001) provides a dimensional scaling of the DSM-IV items for inattention, 
impulsivity, and hyperactivity. In the current study, the 18-item version of the SNAP-IV was 
used. The items are from the DSM-IV (American Psychiatric Association, 1994) criteria for 
Attention-Deficit/Hyperactivity Disorder (ADHD), and include two subscales of symptoms: 
inattention (items 1-9) and hyperactivity/impulsivity (items 11-19). The SNAP-IV is based on a 
four-point Likert rating scale (0 = not at all = 0 to 3 = very much). Subscale scores are calculated 
by averaging the item scores within the domains of Inattention and Hyperactivity/Impulsivity. 
45 
 
 
The SNAP-IV total score was used as a measure of teacher and parent-reported 
inattention/hyperactivity in the current study. Higher scores on the SNAP-IV total score 
represent greater inattention/hyperactivity. Internal consistency for the SNAP-IV total score was 
adequate across reporters (s = .92 - .93). Mother-, father-, and teacher-report of the SNAP-IV 
total score were averaged together to form a single composite score due to significant 
correlations across reporters (r = .44 -.67). 
Executive Dysfunction 
The Behavior Rating Inventory of Executive Function (BRIEF; Gioia, Isquith, Gray, & 
Kenworthy, 2000) is a questionnaire measure of executive function that identifies eight sub-
domains classified within two broader indexes: Behavioral Regulation Index (i.e., inhibit, shift, 
emotional control) and Metacognition Index (i.e., initiate, working memory, plan/organize, 
organization of materials, monitor). The BRI and MI are combined to obtain an overall Global 
Executive Composite (GEC) score. Higher scores on the BRIEF represent higher levels of 
executive dysfunction. The current study used the GEC to capture mother, father, and teacher 
report of youths’ executive dysfunction, which demonstrated satisfactory internal consistency 
across reporters (s = .97 - .98). Mother- and father-reports on the BRIEF-GEC were averaged 
given adequate correlations between reporters (r = .79). Parent- and teacher-report on the 
BRIEF-GEC were separately examined as teacher-report was not correlated with either mother 
or father report (rs = .31 & .16, respectively).  
Academic Functioning 
The scholastic competence subscale from the child, parent and teacher version of the 
Harter (1985) Self-Perception Profile for Children (SPPC) was used to assess academic 
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functioning. Internal consistency was adequate across reporters on the Harter scholastic 
competence subscale (s = .77 – 88). Mother- and father reports on this subscale were 
significantly correlated (r = .81) and averaged together to form a composite score. Teacher report 
was not correlated with either mother or father report (rs= .19 & .21, respectively). Therefore, we 
separately examined parent and teacher report on the scholastic performance subscale.  
Academic functioning was also assessed using mother, father, and teacher reports of the 
grades on the adolescent’s most recent report card. Grades were coded on a scale of 1 to 8, with 
higher scores indicating better grades (e.g., a score of 8 indicated an excellent performance or the 
letter-grade A, a score of 5 represented a satisfactory performance or the letter-grade B/C, a 
score of 1 indicated an unsatisfactory performance or the letter-grade F). Grade point averages 
were computed for four classes: science, social studies, English, and math. Grades across the 
four subjects were first averaged together for each of the three reporters owing to adequate 
reliabilities (s =.63-.85). A composite score was then computed by taking the average of all 
three reporters due to adequate correlations (rs = .65-90). 
Statistical Treatment 
Preliminary Analyses 
Analyses determined whether variables were significantly skewed. Descriptive statistics 
of sleep and diary data were summarized using mean values, frequency distributions, and cross-
tabulations. Descriptive analyses also determined the degree of association among 1) objective 
and subjective sleep summary variables and 2) demographic covariates and sleep summary 
variables, and 3) SB medical variables and sleep summary variables. 
 
47 
 
 
Demographic and Medical Covariates 
The following demographic covariates were chosen due to their potential relation to 
adolescent sleep and bio-neuropsychosocial outcomes: child’s gender, age, pubertal status, and 
family income. During the adolescent period, females are more likely than males to develop 
depression (Nolen-Hoeksema, 2001) and chronic pain (Perquin et al., 2000). Developmental 
(e.g., increased social and academic pressures) and biological (e.g., puberty) may also influence 
sleep patterns in adolescents (Becker, Langberg, & Byars, 2015; Carskadon, Vierira, & Acebo, 
1993), thus, chronological age and pubertal stage may be linked to increased sleep disruption. In 
addition, family income has emerged as a significant correlate of sleep disturbances in youth 
with chronic illnesses (Boergers & Koinis-Mitchell, 2010), as well as obesity and depression in 
the general adolescent population (Goodman, Slap, & Huang, 2003). Low SES may also be 
viewed as a stressor that disrupts parenting and family functioning; lower SES families of 
preadolescents with SB have been found to exhibit higher levels of parent-child conflict and less 
family cohesion (Holmbeck et al., 2002).  
Medical covariates related to condition severity were used in regression analyses to test 
associations between sleep and bio-neuropsychosocial outcomes in the SB group only. These 
medical variables included: lesion level, total shunt revisions (since birth), surgeries and 
hospitalizations (total in previous two years), current gross motor functioning, total prescription 
medication types, and cognitive functioning (IQ). Condition severity has been associated with 
worse neuropsychological functioning in youth with SB, including lower scholastic competence 
and greater symptoms of inattention (Hommeyer et al., 1999). Further, youth with SB with 
greater condition severity often have more complex treatment regimens (e.g., catheterization, use 
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of medications) and a greater number of surgeries and hospitalizations that may disrupt sleep-
wake cycles. A number of prescription medications have the potential to disrupt sleep-wake 
cycles in adolescents with SB, such as antidepressants, anticonvulsants, and antispasmodics (e.g., 
Oxybutynin; Diefenbach et al., 2003).  
Analytic Plan Part 1 (Two-group Analyses; Hypotheses 1 - 3) 
Actigraphic sleep variables were aggregated across nights 1 to 10 for each of the sleep 
parameters. First, MANCOVA/ANCOVA and chi-squared analyses tested for group differences 
in objective and subjective sleep (Hypothesis 1). MANCOVA analyses determined group 
differences in questionnaire report of sleep disturbances (total and subscales scores of the 
ASWS, ASHS, PSAS, and PesdQL-Fatigue). Separate ANCOVAs were run for each of the 
objective sleep scores due to mathematical dependency among several the actigraphy variables 
(Tabachnick & Fidell, 2007), for example, sleep efficiency scores are calculated from average 
total sleep times. The presence of insomnia symptoms (yes/no) was dummy coded (0 = no; 1 = 
yes) and chi-square analyses was utilized to examine group differences in rate of insomnia 
symptoms. 
Daily non-aggregated diary (i.e., daily mood and sleep quality) as well as actigraphic data 
(i.e., total sleep time, efficiency, and minutes awake after sleep onset) were utilized to clarify the 
relationships among daily reports of sleep, mood, and pain (Hypotheses 2 & 3). These data were 
analyzed using hierarchical linear modeling (HLM; Bryk & Raudenbush, 1992) as this is an 
excellent technique specifically designed to test multiple time series data points nested within 
participants. Multilevel modeling offers a number of advantages. First, this technique is 
appropriate for data that have a hierarchical structure. Multilevel modeling also allows for the 
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simultaneous estimation of day-to-day within-person (or Level 1) effects and between-person (or 
Level 2) effects. Other advantages include ability to 1) handle missing data and serial 
dependency without imputing values for within-person (Level 1) missing data, 2) handle unequal 
numbers of observations for each participant, and 3) utilize observations rather than individuals 
as the unit of analysis, expanding the number of degrees of freedom and power. Participants with 
less than 4 consecutive daily diary data were dropped from these analyses.  
To test whether poorer sleep quality and greater sleep fragmentation would predict worse 
pain and mood the following day (Hypothesis 2), we used a 1-day lagged multilevel modeling 
procedure (Model 1 and 2 below). In these first two models, sleep on a given day is hypothesized 
to predict changes in mood and pain from one day to the next. To rule out the possibility that any 
lagged effect of sleep may be due to initial level of the dependent variable, the previous day’s 
mood and pain was included in the model as a control variable. In these first two models, the 
dependent variable is the change in mood or pain from day t to day t +1. The analysis model for 
changes in mood and pain for each individual can be expressed by using the Level 1 equations as 
shown in Models 1 and 2 below. For example, in Model 1 (Sleep predicts mood the following 
day), Mood jt+1 represents the change in person j’s mood score between day t and day t + 1; π0j is 
a regression intercept representing the mean change in daily mood; π1j is a partial regression 
slope representing an individual’s mood on day t; and eti+1 is a residual component of change in 
mood.  
Further, to test Hypothesis 3 that poor daytime mood and more intense pain will predict 
worse nighttime sleep quality and fragmentation (Models 3 and 4 below), daily levels of pain and 
mood were included in the Level 1 equation as predictors of nighttime sleep. Because pain and 
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mood on a given day is hypothesized to predict changes in sleep that night, a 1-day lag model 
was not utilized for these models. The four models were as follows:  
Model 1: Sleep predicts mood the following day 
Level 1: Moodjt+1 = π0j  + π1jMoodjt + π2j (Sleep Parameterjt) + eti+1 
Level 2: π0j = β00 + β01Covariate1j + β02Covariate2 + β03Covariate3j + β04Covariate4j + 
β05GroupStatus j +r0j  
π1j = β10 
π2j = β20 + β21GroupStatusj  
Model 2: Sleep predicts pain the following day 
Level 1: Painjt+1 = π0j  + π1jPainjt + π2j (Sleep Parameterjt) + eti+1 
Level 2: π0j = β00 + β01Covariate1j + β02Covariate2 + β03Covariate3j + β04Covariate4j + 
β05GroupStatus j +r0j   
π1j = β10 
π2j = β20 + β21GroupStatusj  
Model 3: Daytime mood predicts nighttime sleep 
Level 1: Sleepjt = π0j  + π1j (Moodjt) + eti 
Level 2: π0j = β00 + β01Covariate1j + β02Covariate2 + β03Covariate3j + β04Covariate4j + 
β05GroupStatus j +r0j 
π1j = β10 + β11GroupStatusj  
Model 4: Daytime pain predicts nighttime sleep 
Level 1: Sleepjt = π0j  + π1j (Painjt) + eti 
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Level 2: π0j = β00 + β01Covariate1j + β02Covariate2 + β03Covariate3j + β04Covariate4j + 
β05GroupStatus j +r0j 
π1j = β10 + β11GroupStatusj  
In all of the study models, the Level 2 equation included all relevant covariates that 
represent characteristics of the participants. In particular, participant characteristics (age, gender, 
income, pubertal status) and were first entered into baseline multilevel models to determine the 
influence of between-person covariates on daytime mood and pain and nighttime sleep. Next, 
separate multilevel models were run to evaluate 1) sleep parameters (nighttime sleep efficiency, 
WASO, total sleep time, and diary rating of sleep quality) as predictors of mood and pain the 
next day (total of 8 models), and 2) daytime mood and pain as predictors of nighttime sleep 
parameters (total of 8 models), above and beyond the effects of covariates. Therefore, a total of 
sixteen models (four models with each of the four sleep parameters) were run for Hypothesis 2 
and 3 of Analytic Plan Part 1 
Finally, in order to investigate whether day-level relationships between sleep, mood, and 
pain varied as a function of person-level differences in group status (i.e., whether the individual 
had SB or was typically developing), coefficients from the day-level as described at Level 1 of 
model equations were analyzed at Level 2. Thus, study group and the interaction term (Study 
Group X Sleep Parameter, i.e., Study Group X Sleep Efficiency) were added to the models to 
evaluate group as a moderator of sleep, pain, and mood relationships, or person j’s Level 1 slope 
(π2j) is predicted as a function of the intercept and group status. Interaction effects were trimmed 
from study models if non-significant.  
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Analytic Plan Part 2 (SB Group Analyses; Hypothesis 4) 
The final aim of the current study was to identify the relationship between sleep-wake 
disturbances and bio-neuropsychosocial outcomes in adolescents with SB. These analyses were 
conducted for the SB group only. Separate linear regression analyses determined whether study 
independent variables pertaining to sleep-wake disturbances were associated with bio-
neuropsychosocial dependent variables. Specifically, hierarchical multiple regression models 
examined objective and subjective sleep variables as predictors of the following dependent 
variables: BMI, pain intensity, pain frequency, internalizing symptoms, HRQOL, family conflict, 
family cohesion, inattention/hyperactivity, executive function, and academic performance. 
Independent variables were entered in the following order: (Step 1) demographic and medical 
covariates; (Step 2) actigraphic sleep variables; (Step 3) subjective sleep variables. Sleep 
variables (Step 2 and 3) were entered in the forward selection fashion to determine which sleep 
variables were the best predictors of bio-neuropsychosocial functioning.  
Given that the relatively large number of potential objective and subjective sleep 
variables and the smaller sample size used in these single-group analyses presented significant 
power limitations, Pearson correlations were conducted to determine which demographic and 
medical covariates and sleep predictors would be included in multivariate regression models. 
The demographic, medical, and sleep variables that were significantly correlated (p < .05) with a 
bio-neuropsychosocial outcome were included in the corresponding regression model. 
Covariates, subjective sleep, and objective sleep variables were entered into separate steps. If 
more than one objective variable was correlated with a particular bio-psychosocial outcome 
variable, they were run in separate models (one objective variable at a time) due to mathematical 
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dependency among these variables. Models were trimmed to only include significant effects (p < 
.05). Using these methods and because several adult- and child-reported bio-neuropsychosocial 
variables were combined (as described in the Measures section above), a total of 16 regressions 
were run for part two of data analyses.  
Power Analysis 
Power analyses were conducted using G*Power 3 (Faul, Erdfelder, Lang, & Buchner, 
2007). A power of .80 and an alpha of .05 were assumed for all power calculations. For analyses 
including both the SB and TD groups, a sample size of 74 participants were available for 
MANOVA analyses (Hypothesis 1) and 70 participants (4 were excluded, see page 54 below) for 
HLM analyses (Hypotheses 2 & 3). Regression analyses that utilized the SB group only 
(Hypothesis 4) included a sample size of 37 participants.  
For a MANCOVA model with two groups and a maximum of 8 predictors/covariates 
(e.g., five sleep variables and three demographic covariates included), a sample of 70 is required 
to detect medium effect sizes (f
2
 = .25). Thus, our sample size of 74 was deemed to be sufficient 
to detect medium effects for MANCOVA analyses (Hypothesis 1).  
Power calculations are often complex for intensive longitudinal data analyses, and 
therefore power analysis for a two-tailed fixed multiple regression model was used as a 
conservative approximation. This approach for estimating power is likely an underestimation of 
power for fixed effects, as it does not take into account multiple data points that are nested within 
people. For a fixed linear multiple regression model with a maximum of 8 predictors (for the 
most complex hierarchal linear model), a sample size of 70 is required to detect medium effects 
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(f
2
 = .25; Hypotheses 2 & 3). Therefore, a sample size of 70 for combined group analysis was 
determined to be sufficient for Analytic Plan Part 1 (Hypotheses 1-3) 
Finally, for a fixed linear multiple regression model with a maximum of 3 predictors, a 
sample of 37 is required to detect large effects (f
2
 = .35; Hypothesis 4). Therefore, a sample size 
of 37 for single group analysis was determined to be sufficient to detect large effects for Analytic 
Plan Part 2 (Hypotheses 4).
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CHAPTER THREE 
RESULTS 
Preliminary Analyses 
Skewness and Outliers 
Skewness and outlier analyses were run on covariates and non-aggregated and aggregated 
sleep and diary variables for each group and on biopsychosocial variables in the SB group only. 
Conservative alpha levels (.001) were employed to evaluate the significance of skewness and 
outliers, in which z-score values greater than 3.29 were considered significant. A conservative 
approach was taken in the attempt to retain data such that transformations were were performed 
first to reduce the impact of outlier values. Outliers were retained if variable transformations 
were sufficient. However, if transformed variables continued to be significantly skewed, 
significant outliers were removed and data were re-transformed. Square root transformations 
were run first, followed by logarithm and reciprocal transformations, respectively.  
Analyses revealed that the following covariates were significantly skewed: lesion level (z 
= 3.74), number of shunt revisions (z = 4.07), and hospitalizations (z = 3.36). The following non-
aggregated/raw data were skewed for both groups: pain level (SB: z =12.54; TD: z = 14.71), 
sleep efficiency (SB: z = -15.85; TD: z = -14.59), and WASO (SB: z = 6.99; TD z = 18.61). 
Aggregated (averaged) sleep variables that were significantly skewed for the SB group only 
included the pre-sleep arousal total score (z = 4.74) and somatic subscale (z = 5.90). Aggregated 
sleep variables that were skewed for the TD group only included the pre-sleep arousal cognitive 
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subscale (z = 3.51), the adolescent sleep wake scale- reinitiating sleep subscale (z = -3.80), 
WASO (z = 3.83), and nap duration (z = 3.41).  
The majority of variables were no longer significant skewed after transformation 
procedures (z-values < 3.29). Non-aggregated WASO and sleep efficiency variables remained 
significantly skewed for the TD group only (z = 8.55 & z = 5.83, respectively). Removal of 
significant outliers corrected the skew for non-aggregated sleep efficiency (z = 0.56) and WASO 
(TD: z = 1.23). Non-aggregated pain level for both groups continued to be significantly skewed 
after reciprocal transformation (SB: z = -5.26; TD: z = -7.77). However, outliers were retained 
for this variable as re-transforming this variable after their removal did not improve skew. 
Several variables required reversed scale scoring prior to transformation and are displayed (in 
tables) and interpreted (within text) in the opposite direction.  
Descriptive Statistics 
Demographic characteristics and matching information (Table 2). Complete 
demographic information is provided in Table 2. Participants included 37 adolescents with SB 
(56.8% female; M age = 16.1) and a matched group of 37 TD peers (59.5% female; M age = 
16.0). The majority of participants in the total sample were Caucasian (70.3%) and the remaining 
identified as African American (18.9%); Asian American (2.7%), American Indian/Alaskan 
Native (1.4%) or “other” (6.8%). Further, 20.3% of the total sample identified as 
Hispanic/Latino. While a wide range of family incomes were represented in both samples, the 
median (50-59,000k) annual household income suggests a generally middle income sample. The 
majority of the sample (86.1%) was at the late- to post-pubertal stage of development. The 
groups were successfully matched on eight sociodemographic variables: the five primary 
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variables utilized in matching procedures (child age, gender, race, ethnicity, income level) and 
three additional variables (family structure, number of people in the household, pubertal status).  
Table 2. Characteristics of the Study Samples 
Notes. 
Pubert
al 
status 
was 
measu
red 
using 
the 
combi
ned 
gender 
score 
on the 
Pubert
al 
Devel
opmen
t Scale 
(possi
ble 
range 
= 1 to 
4). 
Marita
l 
status 
was 
collap
sed to 
intact 
vs. not 
intact 
(i.e., 
mother/stepfather, single-mother, separated, other). NS = non-significant. SB = Spina Bifida; TD 
= Typically Developing. 
a
Early and mid-pubertal status categories were combined to perform Pearson chi-square test 
 
Characteristic SB Group (N = 
37) 
TD Group (N = 
37) 
Statistical test 
Child age in years: M (SD) 16.1 (1.4) 16.0 (1.5) t(72) = 0.45
NS 
Gender: N (%) 
    Male 
    Female 
 
16 (43.2%) 
21 (56.8%) 
 
15 (40.5%) 
22 (59.5%) 
 
χ2(1) = 0.06NS 
 
Child race: N (%) 
    Caucasian 
    Other  
    
26 (70.3%) 
11 (29.7%) 
 
26 (70.3%) 
11 (29.7%) 
 
χ2(1) = 0.00NS 
Child ethnicity: N (%) 
    Hispanic 
    Non-Hispanic  
    Not Reported/Missing 
    
  8 (21.6%) 
29 (78.4%) 
  0  (0.0%) 
 
   7 (18.9%) 
 28 (75.7%) 
   2  (5.4%) 
 
χ2(1) = 0.03NS 
Family income level  
   Median level 
   Categories: N (%) 
      <$29,000 
      $30,000 – 49,000 
      $50,000 – 69,000 
      >$70,000 
 
6.0 (50-59,000k) 
 
10 (29.4%) 
6 (17.6%) 
3 (8.8%) 
15 (44.1%) 
 
6.0 (50-59,000k) 
 
4 (10.8%) 
8 (21.6%) 
9 (24.3%) 
16 (43.2%) 
 
F(1) = 1.39
NS
 
 
χ2(3) = 5.77NS 
 
 
 
Family structure: N (%) 
    Two-parent intact 
    Not intact 
 
25 (71.4%) 
10 (28.6%) 
27 (73.0%) 
10 (27.0%) 
 χ2(1) = 0.02NS 
 
People in household: M 
(SD) 
4.5 (1.4) 4.6 (1.6) t(70) = -0.31
NS
 
Pubertal Development 
    Total Score: M (SD) 
    Categories: N (%)
a
 
       Early pubertal 
       Mid pubertal 
       Late pubertal 
       Post pubertal 
 
3.3 (0.5) 
 
  1 (2.9%) 
  2 (5.7%) 
19 (54.3%) 
13 (37.1%) 
 
3.2 (0.7) 
 
  4 (10.8%) 
  3 (8.1%) 
19 (51.4%) 
11 (29.7%) 
 
t(70) = 0.55
NS
 
 
χ2(2) = 1.72NS 
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Medical characteristics. Information on a number of physical status/illness severity 
variables for the SB group was obtained from medical chart review and/or parent report when 
chart data were unavailable: (a) SB type (chart and parent): 91.9% myelomeningocele, 2.7% 
lipomeningocele, and 5.7% lipoma, (c) shunt status (chart and parent): 78.4% shunt, 21.6% no 
shunt (b) spinal lesion level (chart): average lesion level was approximately in the L4 region, (d) 
gross motor functioning class (GMFC; parent): 13.5% Level I, 24.3% Level II, 27.0% Level III, 
32.4% Level IV (2.7% or N = 1 unknown), (f) total number of shunt revisions among those with 
shunts (parent; M = 2.2, SD = 2.2; range = 0-8), (g) number of surgeries in previous two years 
(parent; M = 0.7, SD = 0.0; range = 0-3), and (h) current prescription medication (parent): 8.1% 
antidepressants, 8.1% anticonvulsants, 48.6% antispasmodics, 8.1% stimulants, and 0% opioids. 
None of the adolescents in the TD group were prescribed any of the aforementioned medications. 
Sleep disordered breathing. Symptoms of sleep-disordered breathing were also assessed 
in the SB group only. Habitual snoring, which was defined as snoring more than half the time 
while asleep, was reported in 5.4% (N = 2) of adolescents with SB. A score suggestive of sleep 
disordered breathing (SDB; > .33) was found in one fifth (21.6%) of the sample of adolescents 
with SB. 
Sleep assessment completion information. All participants completed actigraphic 
monitoring (N = 74). However, 4 youth from the SB sample had incomplete or unusable diary 
data: 3 participants were diary non-completers and 1 had non-consecutive diary data. SB 
participants with complete (N = 33) and unavailable/unusable (N = 4) diary data were similar 
according to age (t[35] = -.48, p = .64), sex (2 [1] = .08, p = .77), race (Caucasian or other; 2 
[1]
 
= 1.90, p = .17), ethnicity (Hispanic or Non-Hispanic; 2 [1] = 0.03, p = .86) income (t[35] =  
59 
 
   
 
-.96, p = .35), type of SB (myelomeningocele or other; 2 [1] = 1.72, p = .19), and shunt status 
(2 [1] = .001, p = .97). Pearson product correlations determined that demographic and medical 
characteristics were unrelated to sleep assessment completion rate (i.e., number of actigraphy 
days and number of diary days, ps = -.23 - .33).  
SB participants completed an average of 8.9 days out of the possible 10 days of 
actigraphic monitoring (89% completion rate; range = 5–12) and TD youth completed an 
average of 9.2 days (92% completion rate; range = 6-11). Youth with SB with valid diary data 
completed an average of 18.2 diary entries (91% completion rate; range = 6–20) out of the 
possible 20 diary entries (2 entries per day for 10 days) during the data collection period, and TD 
youth completed an average of 18.4 diary entries (92% completion rate; range = 10-29). Data 
from 614 diary days and 607 actigraphy nights were available for analyses.  
Associations among objective and subjective sleep summary scores (Tables 3 & 4). 
There were significant correlations among actigraphic sleep and self-reported sleep variables by 
group. Both diary-report and questionnaire-report of sleep quality were included in these 
analyses. In the SB sample, lower average total sleep time was associated with lower diary-
reported sleep quality (r = .37, p =.03). Greater variability in total sleep time (i.e., sleep 
variability) was associated with poorer self-reported sleep habits (r = -.34, p = .04) in this 
sample. For TD youth, greater sleep variability was associated with greater pre-sleep arousal (r = 
.38, p = .03) and longer average nap duration was associated with greater symptoms of insomnia 
(r = .39, p = .02).  
There were also several significant associations found among the actigraphy sleep 
variables (see Table 3). Strong correlations were found among total sleep time, WASO, and 
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sleep efficiency across both groups, with shorter total sleep time associated with greater minutes 
awake after sleep onset (SB: r = -.75; TD: r = -.55; p-values < .01) and poorer sleep efficiency 
(SB: r = .83; TD: r = .70; p-values < .01). Greater sleep variability was also associated with 
longer daytime naps in the SB group (r = .38, p = .03). 
Table 3. Bivariate Correlations among Demographic and Actigraphy Sleep Summary Variables 
by Group 
Variables 1   2    3    4    5    6    7    8    9 
1. Gendera -- -.03 -.25 .28 -.22  .15 -.16  .23  .35* 
2. Age  .07 -- -.01 .52*  .13 -.09  .10  .29  .27 
3. Incomeb  .13  .03 -- .21 -.23  .10 -.13 -.08  .16 
4. Pubertal Status  .71*  .20  .18 -- -.09  .07 -.11  .13  -.03 
5. Total Sleep Time  .30 -.40* -.11  .27 -- -.75*  .83* -.18 -.21 
6. WASO -.55*  .31* -.32 -.50* -.55* -- -.96*  .07  .09 
7. Sleep Efficiency  .62* -.30  .19  .51*  .70* -.93* -- -.14 -.09 
8. Sleep Variability  .11  .31 -.26  .28 -.05 -.07 -.01 --  .38* 
9. Nap Duration -.18  .05  .09  .00 -.21 -.10  .02 -.05 -- 
Notes. The numbers above the diagonal comprise correlations in sample of adolescents with 
spina bifida (Ns range from 34 to 37) and the lower triangle comprises correlations in sample of 
typically developing adolescents (Ns range from 35 to 37); WASO = minutes awake after sleep 
onset; Sleep Variability = average variation in Total Sleep Time.  
a
Gender coded as 0 = male, 1 = female 
bSpearman’s rho  
*p < .05 
 
Of note, there was a strong correlation between WASO and sleep efficiency (SB: r = -
.96; TD: r = -.93; p-values < .01), likely due to mathematical redundancy between the two 
variables. While these two actigraphic variables have strong quantitative overlap, previous sleep 
research has included both variables due to their conceptual differences. Sleep efficiency is 
frequently reported in sleep research as an interpretable and meaningful metric of sleep quality or 
the amount of time adolescents spend sleeping while taking into account sleep latency and 
nighttime awakenings; however, WASO may be useful to specifically determine the average 
amount of time youth are awake during the nighttime. Thus, both measures were included in our 
61 
 
   
 
analyses. However, due to mathematical redundancy, these two variables were never included in 
the same analytic models (e.g. regression and MANOVA models).  
Finally, there were significant correlations among subjective sleep disturbances in the 
expected directions (see Table 4; rs = -.75 - .72, ps < .05). However, for youth with SB, 
symptoms of insomnia were unrelated to sleep habits, pre-sleep arousal, and fatigue.  
Table 4. Bivariate Correlations among Demographic and Subjective Sleep Summary Scores by 
Group 
Variables 1     2     3    4    5 6     7    8    9    10 
1. Gendera -- -.03 -.27 .28 -.55* -.16 -.17  .32  .13 -.42* 
2. Age  .07 -- -.01 .52*  .14  .10 -.36* -.07 -.14  .07 
3. Income Levelb  .13  .03 -- .21  .08 -.27  .05 -.12  .04  .27 
4. Pubertal Status  .71*  .20  .18 -- -.05 -.22 -.34* -.01  .11 -.03 
5. Sleep Quality (Q) -.01 -.10  .17  .03 --  .29  .39* -.64* -.44*  .72* 
6. Sleep Quality (D) -.14 -.04 -.08 -.02  .55* --  .17 -.35* -.07  .35* 
7. Sleep Habits   .11 -.09  .09  .11  .72*  .46* -- -.49* -.25  .59* 
8. Pre-sleep Arousal -.05  .14 -.18 -.07 -.75* -.46* -.76* --  .25 -.72* 
9. Insomniac  .03  .14 -.10  .05 -.61* -.48* -.42*  .39* -- -.25 
10. Fatigued  .14 -.08  .01 -.02  .55*  .38*  .49* -.59* -.33* -- 
Notes. The numbers above the diagonal comprise correlations in sample of adolescents with 
spina bifida (Ns range from 34 to 37) and the lower triangle comprises correlations in sample of 
typically developing adolescents (Ns range from 35 to 37); Q = Questionnaire report of sleep 
quality (i.e., the ASWS, Adolescent Sleep Wake Scale); D= Diary report of sleep quality 
averaged across diary days (Global Score 1-10).  
a
Gender coded as 0 = male, 1 = female 
bSpearman’s rho  
c
Insomnia coded as 0 = no, 1 = yes, derived from two items on the ASWS (sleep initiation and 
maintenance). 
d 
Lower scores on the PedsQL Multidimensional Fatigue Scale indicate greater problems with 
fatigue 
*p < .05 
 
Across both groups, lower diary-reported sleep quality was associated with greater pre-sleep 
arousal (SB: r = -.35; TD: r = -.46; p-values < .05) and fatigue (SB: r = .35; TD: r = .38; p-
values < .05). Lower diary-reported sleep quality was also associated with questionnaire-report 
of sleep quality (i.e., ASWS total score, r = .55, p < .01), insomnia symptoms (r = -.48, p = 
.003), and sleep habits r = .46, p = .005) in the TD group.  For the SB group, snoring was 
62 
 
   
 
unrelated to any other subjective sleep measures (ps > .05), however, more symptoms of 
sleepiness were related to lower questionnaire-report of sleep quality (r = -.34, p = .04) and 
greater fatigue (r = -.41, p = .01). 
Associations among demographic and sleep summary scores by group (Tables 3 & 
4). Correlations among the demographic and sleep-wake variables were calculated to determine 
which demographic covariates would be included in Part 1 of study analyses. Results indicated 
that, for the SB group, female gender was associated with lower questionnaire-report of sleep 
quality (r = -.55), greater fatigue (r = -.42), and longer daytime naps (r = .35). Further, older age 
and more advanced pubertal status were associated with worse sleep habits (r = -.36 & r = -.34, 
respectively ps < .05) in this sample. For the TD group, female gender and more advanced 
pubertal status was associated with better sleep efficiency (r = .62 & r = .51, respectively) and 
fewer minutes awake after sleep onset (r = -.55 & r = -.50, respectively). Finally, older age was 
associated with shorter total sleep time (r = -.40) and more time awake after sleep onset (r = .31) 
in the TD sample. In sum, while females and those with more advanced pubertal status reported 
worse subjective sleep disturbances in the SB group, the opposite was true for the TD group (i.e., 
females and those with more advanced pubertal status showcased better objective sleep). 
However, older adolescent age was associated with greater sleep disturbances in both groups. 
Income was not significantly associated with sleep disturbances in either group (ps >.05). Results 
of bivariate correlations indicated that the following demographic variables were included in 
Part 1 of study analyses (two-group study design): age, gender, and pubertal status.  
The sleepiness and snoring subscales of the PSQ were calculated for the SB group only 
(not included in Tables 3 & 4); bivariate associations among demographic characteristics and the 
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two PSQ subscales indicated that male gender and less advanced pubertal status was associated 
with more snoring symptoms (r = -.39 & r = -.52 p = .002).   
Associations between medical and sleep summary scores in the SB group (Tables 5 
& 6). Descriptive analyses indicated that the presence of a shunt was associated with longer 
average sleep time (r = .37; see Table 5). Further, more limited gross motor functioning was 
associated with worse fatigue (r = -.46) and greater sleepiness (r = .44; see Table 6).  
Table 5. Bivariate Correlations among Medical Covariates and Actigraphy Sleep Summary 
Scores in the SB Group 
Variables     1     2     3    4    5    6    7    8 9 10 11 12 13 
1. Shunt Statusa  --             
2. Lesion Levelb  -.12 --            
3. Shunt Revisionsc   .52* -.03 --             
4. Surgeriesc   .24 -.30 .27 --          
5. Hospitalizationsc  .06  .04 .17 .58*  --          
6. GMF  .08  .47* .04 .06  .30 --         
7. Rx Medicationd -.03  -.01 .23 .24  .34*  .10 --       
8. WASI -.03 -.40* .07 .22  .04 -.04  .04 --      
9. Total Sleep Time  .37*  .29 .04 -.12 -.06  .17 -.20 -.23 --     
10. WASO -.13 -.16 .17 .19  .13 -.12  .25 -.08 .75* --    
11. Sleep Efficiency  .17  .19 -.14 -.18  -.11  .13 -.21 -.01  .83* -.96* --   
12. Sleep Variability -.06  .15  .08 .25  .20  .30  .23 -.01 -.18  .07 -.14 --  
13. Nap Duration -.11 -.11 -.21 .04 -.32  .07  -.22 .07 -.21  .09 -.09 .38* -- 
Notes. GMF = Gross motor functioning (higher scores indicate higher level of impairment); 
WASI = Wechsler Abbreviated Scale of Intelligence;  
WASO = minutes awake after sleep onset; Sleep Variability = average variation in Total Sleep 
Time. 
a
Shunt status coded as 1 = present; 0 = absent/no shunt 
b
Lesion level coded such that sacral lesions levels had lowest scores and thoracic had highest 
scores 
c
Total number; Shunt revisions are total in lifetime, surgeries and hospitalizations are total in 
previous two years  
d
Rx medications represent the total number of types of prescription medications taken (e.g., 
antidepressants, anticonvulsants, etc.) 
*p < .05. 
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Hypotheses Testing 
Overview of Part I (Addressing Hypotheses 1-3) 
Part I of this project is a two-group study design utilizing a comprehensive sleep 
assessment including objective (actigraphy) and subjective (questionnaire and daily diary) 
measures. First, MANCOVAs and ANCOVAs first tested for group differences in objective and 
subjective sleep using aggregated actigraphic and subjective measures, respectively (Hypothesis 
1). Next, multilevel regression models tested for relationships among daily reports of sleep, 
mood, and pain among the two groups using non-aggregated diary data (Hypotheses 2 & 3). All 
two-group analyses controlled for the effects of child age, gender, and pubertal status.  
Group comparisons on objective and subjective sleep disturbances (Hypothesis 1) 
Objective sleep-wake disturbances (Table 7). As hypothesized, there were significant 
differences on actigraphic assessment of sleep-wake patterns between adolescents with SB and 
typically developing (TD) adolescents. Adolescents with SB experienced significantly shorter 
total sleep time at 6.15 hours (368.9 min) per night on average (SD = 1.11 hrs) compared with 
6.62 hours (397.0 min) per night in TD adolescents (SD = 0.84 hrs, p = 0.04). Exploratory chi-
squared analyses found that almost half (43.2%) of adolescents with SB experienced extremely 
short sleep (defined as less than 6 hours), compared with 21.6% of TD adolescents (2 [1] = 3.95, 
p < .05).  Youth with SB also evidenced greater sleep variability, such that variability in nightly 
total sleep time was greater compared to their peers.  
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Table 6. Bivariate Correlations among Medical Covariates and Subjective Sleep Summary 
Scores in the SB Group 
Variables 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1. Shunt Statusa  --                
2. Lesion Levelb -.12 --               
3. Shunt 
Revisions
c
  
 .52
*
 -.03 --                
4. Surgeriesc   .24 -.30 .27 --             
5. Hospitalizationsc   .06  .04 .17 .58*  --             
6. GMF   .08  .47* .04 .06  .30 --            
7. Rx Medicationd -.03  -.01 .23 .24  .34*  .10 --          
8. WASI -.03 -.40* .07 .22  .04 -.04  .04 --         
9. Sleep Quality 
(Q) 
 .02  .05 .04 .04 -.03 -.25 -.22 -.12 --        
10. Sleep Quality 
(D) 
.32 02 .28 -.11 -.26 -.17 -.22 -.09 .29 --       
11. Sleep Habits -.01  .05 .15 .01  .01 -.30 -.07 -.13  .39*  .17 --      
12. Pre-sleep 
Arousal 
-.09  .06 -.01 .20  .26  .21  .12  .08 -.64
*
 -.35
*
 -.49
*
 --     
13. Insomniae  .22 -.08 .11 -.07 -.04  .13 -.12  .08 -.44* -.07 -.25  .25 --    
14. Fatiguef   .09 -.19 .18 .06 -.15 -.46* -.09  .02  .72*  .35  .59* -.72*  -.25 --   
15. Sleepinessg -.19  .21 -.11 .03  .10  .44*  .08  .13 -.34* -.29  -.21  .13 .08 -.41* --  
16. Snoringg -.25  .21 -.02 -.07  .13  -.05 -.33  -.13  .17 -.09  .04  .06 -.01 .04 -.10 -- 
Notes. GMF = Gross motor functioning (higher scores indicate higher level of impairment); 
WASI = Wechsler Abbreviated Scale of Intelligence; Q = Questionnaire report of sleep quality 
(i.e., the ASWS, Adolescent Sleep Wake Scale); D= Diary report of sleep quality averaged 
across diary days (Global Score 1-10). 
a
Shunt status coded as 1 = present; 0 = absent/no shunt 
b
Lesion level coded such that sacral lesions levels had lowest scores and thoracic had highest 
scores 
c
Total number; Shunt revisions are total in lifetime, surgeries and hospitalizations are total in 
previous two years  
d
Rx medications represent the total number of types of prescription medications taken (e.g., 
antidepressants, anticonvulsants, etc.) 
e
Insomnia coded as 0 = no, 1 = yes, derived from two items on the ASWS (sleep initiation and 
maintenance). 
f 
Lower scores on the PedsQL Multidimensional Fatigue Scale indicate greater problems with 
fatigue.
 
g
Subscales of the Pediatric Sleep Questionnaire; calculated for the SB group only. 
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Table 7. Between-Group Comparisons on Actigraphy Sleep Summary Scores 
Sleep Variable SB Group 
Mean (SD) 
TD Group 
Mean (SD) 
F-value p-value 2 
  Total Sleep Time (min)   
      [M hrs, min] 
368.9 (65.6) 
[6 hrs, 9 min] 
397.0 (50.3) 
 [6 hrs, 37 min] 
F1, 67 = 4.28* .042 .06 
  Sleep Efficiency (%) 75.0 (11.6) 83.3 (5.4) F1, 67 = 15.35** <.001 .19 
  WASO (minutes) 117.2 (62.3) 64.9 (26.3) F1, 67 = 21.84** <.001 .25 
  Sleep Variability 19.3 (8.4) 15.3 (6.6) F1, 67 = 5.10* .027 .07 
  Nap duration (minutes) 44.8 (62.2) 44.2 (61.6) F1, 63 = 0.001 .972 <.01 
Notes. ANCOVAs were run for each objective score (vs. one MANCOVA) because several of 
the variables were mathematically dependent. Displayed means and SDs are non-transformed 
variables adjusted for covariates (age, gender, pubertal status). WASO = minutes awake after 
sleep onset; Sleep Variability = average variation in total sleep time; SB = spina bifida; TD = 
typically developing; 2= partial eta squared.  
+p = .05-09; *p < .05; **p < .01 
 
Further, the SB group also spent more time awake after sleep onset, averaging 1.95 hrs 
(117.2 minutes) per night on average (SD = 62.3) compared with a little over an hour (64.5 
minutes) in TD adolescents (SD = 38.3; p <.001). Consequently, adolescents with SB had 
significantly poorer sleep efficiency (M= 75.0; SD = 11.6) compared with TD adolescents (M= 
83.3, SD = 5.4; p < 0.001). Chi-squared analyses indicated that over half (56.8%) of adolescents 
with SB had poor sleep efficiency (defined as less than 80%) compared to 18.9% of TD 
adolescents (2[1] = 11.26, p < 0.01). There were no group differences in average daytime nap 
duration. Group differences in wake after sleep onset and sleep efficiency represented large 
effect sizes, while differences in total sleep time and sleep variability were medium effects.  
Subjective sleep-wake disturbances (Tables 8 & 9). Table 8 presents group differences 
and adjusted means/standard deviations of questionnaire sleep-wake summary variables and 
Table 9 displays between-group comparisons on insomnia symptoms.  
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Table 8. Between-Group Comparisons on Questionnaire Sleep Summary Scores 
Variable SB Group 
Mean (SD) 
TD Group 
Mean (SD) 
F-value p-value 2 
Summary Scores      
     F4, 64 = 4.10**  .005 .20 
Sleep Quality (ASWS) 4.0 (0.7) 4.5 (0.6) F1, 67 = 10.67** .002 .14 
Sleep Habits (ASHS) 4.7 (0.7) 5.0 (0.5) F1, 67 = 4.21*
 
.044 .06 
Pre-sleep Arousal (PSAS) 29.1 (12.6) 25.4 (6.5) F1, 67 = 2.20 .143 .03 
Fatigue (PedsQL- MFS) 64.5 (18.2) 76.7 (11.9) F1, 67 = 12.14** .001 .15 
Subscale Scores      
Sleep Quality (ASWS)   F5, 61 = 6.56** <.001 .35 
  Going to bed 3.5 (1.0) 4.2 (0.9) F1, 65 = 10.57** .002 .14 
  Falling asleep 4.2 (1.0) 4.7 (0.9) F1, 65 = 6.14* .016 .09 
  Maintaining sleep 4.5 (0.9) 4.7 (0.7) F1, 65 = 1.70 .196 .03 
  Reinitiating sleep 4.4 (0.9) 5.3 (0.7) F1, 65 = 24.23** <.001 .27 
  Returning to 
wakefulness 
3.6 (1.4) 3.5 (0.9) F1, 65 = <0.03 .884 <.01 
Sleep Habits (ASHS)
 
  F4, 61 = 1.35 .237 .08 
  Cognitive
 
4.0 (1.0) 4.2 (0.8) F1, 64 = 0.25 .619 <.01 
  Emotional 4.9 (1.3) 5.1 (0.7) F1, 64 = 0.66 .419 .01 
  Sleep environment 4.7 (1.1) 5.2 (0.8) F1, 64 = 4.54* .037 .07 
  Sleep stability 3.5 (1.5) 4.0 (1.0) F1, 64 = 2.08 .154 .03 
Pre-Sleep Arousal (PSAS)      
  Somatic  12.1 (5.6) 10.4 (2.6) F1, 67 = 2.60 .112 .04 
  Cognitive 17.0 (8.1) 14.9 (4.8) F1, 67 = 1.50 .226 .02 
Fatigue (PedsQL- MFS)
a 
  F3, 65 = 7.32**  <.001 .25 
  General 70.8 (19.9) 78.6 (13.0) F1, 67 = 3.97
+
 .050 .06 
  Sleep/Rest 60.7 (21.4) 70.6 (14.7) F1, 67 = 5.42* .023 .08 
  Cognitive 62.0 (22.1) 80.9 (14.2) F1, 67 = 20.83** <.001 .24 
Notes. Bolded lines represent omnibus MANCOVA results, with univariate follow-up analyses 
presented underneath. ANCOVAs were run for each subscale of the ASHS (vs. one 
MANCOVA) due to lower correlations among the subscales. Displayed means and SDs are non-
transformed variables adjusted for covariates (child age, gender, pubertal status). SB = spina 
bifida; TD = typically developing; 2= partial eta squared. ASWS = Adolescent Sleep-Wake 
Scale; ASHS = Adolescent Sleep Hygiene Scale; PSAS = Pre-Sleep Arousal Scale; PedsQL- MF 
= Pediatric Quality of Life Inventory, Multidimensional Fatigue Scale.  
a 
Lower scores on the PedsQL Multidimensional Fatigue Scale indicate greater problems with 
fatigue
 
+p = .05 - .09; *p < .05; **p < .01 
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Table 9. Between-Group Comparisons on Insomnia Symptoms 
Insomnia Symptoms SB Group 
   N (%) 
TD Group 
   N (%) 
2 p-value 
  1) Difficulty falling asleep  
     (>60%   of the time)
 
7 (19.4) 7 (18.9) .003 .955 
  2) Difficulty staying asleep  
     (>60% of the time)   
9 (25.7) 3 (8.1) 4.01* .045 
  Either 1) or 2)  11 (31.4) 8 (21.6) 0.89 .345 
  Both 1) and 2)  5 (14.3) 2 (5.4) 1.62 .204 
Notes. Insomnia symptoms were evaluated using two items from the ASWS assessing difficulty 
falling asleep and difficulty maintaining sleep. SB = spina bifida; TD = typically developing 
*p < .05 
 
The overall MANCOVA including questionnaire sleep-wake summary scores was significant 
(F4, 64 = 4.10, p = .01). As hypothesized, adolescents with SB reported significantly worse overall 
sleep quality (on the Adolescent Sleep Wake Scale; ASWS) and greater fatigue (PedsQL-Fatigue 
Scale; PedsQL-FS) compared with healthy adolescents, which were large effects (ps < .001; 
Table 8). Adolescents with SB also endorsed worse sleep habits on the Adolescent Sleep Habits 
Scale (ASHS) compared to their peers (p = .04), which was a medium effect. There were no 
differences in the pre-sleep arousal (PSAS) summary score between the two groups 
The overall MANCOVA for the subscales of the ASWS was also significant (F5, 61 = 
6.56, p < .001; Table 8). Compared with typically developing peers, adolescents with SB 
reported more difficulties with going to bed and reinitiating sleep, which were large effects. They 
also reported greater difficulties falling asleep (p = 0.02), which was a medium effect. Gender 
emerged as a significant covariate in the MANCOVA model (F1, 61 = 2.99, p = .02); compared to 
adolescent males, females had greater difficulties going to bed (F1, 65 = 5.50, p = .02), falling 
asleep (F1, 65 = 10.48, p = .002), reinitiating sleep (F1, 65 = 5.59, p = .02), and returning to 
wakefulness (F1, 65 = 5.96, p = .02).  
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Further, the overall MANCOVA for the subscales of the ASHS was not significant, 
indicating similarity between groups on sleep habits (F4, 61 = 1.34, p = .24). However, because 
adolescents with SB had significantly worse ASHS total scores in the overall MANCOVA 
including questionnaire summary scores, we proceeded to examine mean differences among 
individual subscales of the ASHS. As shown in Table 8, there was a significant group difference 
in mean levels of the sleep environment subscale of the ASHS, such that adolescents with SB 
reported worse sleep environments compared to TD peers (p = 0.04).  
Further, the overall MANCOVA for the subscales of the PedsQL-FS was significant, 
indicating that adolescents with SB reported greater daytime fatigue compared with healthy 
adolescents (F3, 65 = 7.32, p < .001). Examining the individual subscales of the PedsQL-FS 
indicated that adolescents with SB reported more difficulties with sleep/rest (p = 0.02) and 
cognitive fatigue (p < .001) compared to their TD peers, which were medium and large effects, 
respectively. There was also a trend toward adolescents with SB reporting more difficulties with 
general fatigue (p = .05).  
There were no differences in the pre-sleep arousal subscale scores (cognitive and somatic 
arousal before bedtime) between the two groups. However, pubertal development emerged as a 
significant covariate for somatic pre-sleep arousal (F1, 61 = 2.96, p = .019), such that more 
advanced pubertal development was associated with less somatic pre-sleep arousal.  
As shown in Table 9, the prevalence of insomnia symptoms was evaluated using two 
items from the ASWS assessing difficulty falling asleep and difficulty maintaining sleep. 
Adolescents reporting either symptom were judged to have insomnia symptoms. Chi-squared 
analyses indicated that a similar proportion of adolescents with SB reported insomnia (31.4%) 
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compared to typically developing adolescents (21.6%; 2 = 0.89, p = .345). However, when 
examining individual insomnia symptoms, difficulties staying asleep were reported at 
significantly higher rates in adolescents with SB (25.7%) compared to their TD peers (8.1%; 2 = 
4.01, p = .04). There were no group differences in self-reported difficulties falling asleep.  
Daily Associations among Sleep, Mood, and Pain (Hypotheses 2 & 3) 
Descriptive daily actigraphy and diary information. Descriptive analyses were 
performed on non-aggregated (multilevel or raw) actigraphy and diary data. Across all diaries, 
the average sleep quality ratings were moderate (M = 7.4 [out of 10], SD = 2.0, range = 1.0 - 10) 
average mood ratings were positive (M = 6.8 [out of 10], SD = 2.2, range = 0.0- 10), and average 
pain intensity was mild (M = 1.1 [out of 10], SD = 2.0, range = 0 - 10. Youth with SB reported 
sleep quality in the lower range (1SD below the mean of sleep quality, i.e., < 5.4, reflecting 
poorer sleep quality) on a similar number of observations as their TD peers (15.0% vs. 18.7% of 
days; respectively; 2 [1] = 1.59, p = 0.21). Adolescents with SB also reported mood in the lower 
range (1SD below the mean mood, i.e., < 4.6, reflecting more negative or lower mood) and on a 
similar percentage of diary days as the TD participants (16.7% vs. 12.8% of days, respectively; 
2 [1] = 1.94, p = 0.16). Finally, youth with SB reported pain on a similar number of diary days 
(36.0%) compared to their TD peers (29.4%) of days during the study period (2 [1] = 3.13, p = 
0.08), and average pain ratings on days in which pain occurred was largely equivalent and in the 
mild range across the the two groups (M = 3.36 vs. M = 3.74 in SB and TD youth, respectively; 
t(204) = -1.34, p = .18). 
Descriptive analyses of non-aggregated actigraphy data indicated that adolescents with 
SB and TD adolescents experienced a higher percentage of nights of extremely short total sleep 
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time (<6.0 hrs sleep; SB: 44.9%; TD: 30.7%, 2 [1] = 13.51, p < 0.001) and low sleep efficiency 
(i.e., less than 80%; SB: 49.0% vs. TD: 24.3%, 2 [1] = 40.62, p < 0.001). Youth with SB also 
experienced time awake after sleep onset (WASO) in the upper range (>1SD above the mean 
WASO, i.e., > 158.7 minutes) on a higher percentage of (27.1%) compared to 1.5% of TD youth, 
2 [1] = 85.42, p < 0.001.  
Baseline multilevel model analyses. Participant characteristics (group, age, gender, 
income, pubertal status) and the previous’ day mood or pain variable (when applicable) were 
entered into baseline multilevel models. Results indicated that previous day’s mood was 
positively associated with next-day mood (est = 0.20, SE = .04, p < .001). Previous day’s pain 
intensity was also positively associated with pain intensity the following day (est = .20, SE = .04, 
p < .001). Study group emerged as a significant predictor of total sleep time, sleep efficiency, 
and diary-reported sleep quality. Specifically, youth with SB experienced shorter sleep time (est 
= 30.0, SE = 14.3, p = .04), lower sleep efficiency (est = .91, SE = .26, p = .001), and higher 
WASO (est = 2.33, SE = .54, p < .001) across the sleep assessment period. Counterintuitively, 
youth with SB reported better sleep quality (est = -.84, SE = .38, p = .03). None of the 
demographic covariates predicted sleep, daytime mood or pain intensity in these models. 
Our original data analytic plan was to estimate the slope parameter and interaction term (e.g., 
Study Group X Sleep Efficiency) in each model. However, preliminary analyses found that none 
of the interaction terms were significant and were therefore dropped from all models to increase 
power. Dropping the interaction term also allowed for the elimination of slope parameters, and, 
thus, estimation of random-intercept-only models. This decision was made because estimating 
slope parameters decreases power to detect within-person effects (Bolger & Laurenceau, 2013). 
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Nighttime sleep disturbances as predictors of daytime mood and pain (Hypothesis 2; 
Table 10).  Separate models evaluated actigraphic sleep efficiency, WASO, total sleep time, and 
diary-reported sleep quality as predictors of mood (four models) and pain (four models) the next 
day, above and beyond the effects of demographic covariates. As hypothesized, nighttime sleep 
efficiency, total sleep time, and diary-reported sleep quality were significantly related to mood 
the following day (ps < .05). Specifically, lower sleep efficiency, shorter sleep time, and poorer 
diary-reported sleep quality predicted worse mood the next day. Contrary to hypotheses, there 
was no significant effect of WASO, or number of minutes awake following sleep onset, on 
daytime mood. In addition, as hypothesized, WASO predicted pain intensity the next day, with 
greater number of minutes awake after sleep onset associated with higher pain the following day 
(p = .04). Contrary to hypotheses, nighttime sleep efficiency, sleep time, and diary-reported sleep 
quality did not predict pain intensity the next day.  
Table 10. Estimates for Multilevel Models of Nighttime Sleep Disturbances Predicting Daytime 
Mood and Pain  
 Daytime Mood  Daytime Pain  
Fixed Effects Est SE t  Est SE t 
   Sleep Efficiency  0.19 0.08  2.41*  -0.02 0.02 -1.05 
   Study Group -0.67 0.53 -1.27  -0.04 0.04 -1.03 
   WASO   0.03 0.03  1.07   0.02 0.01  2.04* 
   Study Group -0.66 0.52 -1.28  -0.04 0.04 -1.01 
   Total Sleep Time  0.01 <0.01  5.79**  <-0.01 <0.01 -0.23 
   Study Group -0.50 0.39 -1.28  -0.04 0.04 -0.98 
   Sleep Quality   0.49 .05  10.74**   0.01 0.01  0.73 
   Study Group -0.50 .41 -1.22  -0.03 0.05 -0.60 
Notes. The number of subjects was 68 and the total number of observations was 475-539 in 
models of nighttime sleep predicting daytime mood or pain. Models controlled for previous 
day’s mood/pain, age, gender, and pubertal status. Sleep variables were person-centered by 
subtracting each person’s mean rating from all of their daily ratings to represent within-person 
effects. Est = Estimate; WASO = Time Awake after Sleep Onset; Study Group is coded as 0 = 
SB and 1 = TD. 
*p < .05; **p < .01 
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Daytime mood and pain as predictors of nighttime sleep disturbances (Hypothesis 3; 
Table 11). Next, separate models evaluated daytime mood and pain as predictors of all the four 
sleep parameters, above and beyond the effects of demographic covariates. There was no 
significant main effect of daytime pain on nighttime sleep parameters. However, contrary to 
hypotheses, higher daytime mood predicted reduced total sleep time (p = .03) and lower sleep 
quality. Consistent with baseline models, study group emerged as a significant main effect for 
the majority multilevel models predicting sleep parameters; youth with SB experienced lower 
sleep efficiency, shorter sleep time, higher WASO, and better nighttime sleep quality (ps < .05).  
Group status became non-significant in the model with pain intensity predicting total sleep time 
(p > .05).  
Table 11. Estimates for Multilevel Models of Daytime Mood and Pain Predicting Nighttime 
Sleep Disturbances 
 Sleep Efficiency WASO Total Sleep Time Sleep Quality 
Fixed 
Effects 
Est SE t Est SE t Est SE t Est SE t 
Daytime 
Mood  
-0.02 .03 -0.66 -0.05 .07 -0.47 -4.72 2.39 -1.97* -0.10 0.04 -2.39* 
Study 
Group 
 0.85 .26  3.24** -2.18 .53 -4.08** 29.65 14.27  2.08* -1.12 0.38 -3.00** 
Pain 
Intensity 
 0.08 .16  0.51 -0.50 0.38 -1.30 -5.23 11.97 -0.44 -0.31 0.22  1.39 
Study 
Group 
 0.87 .27 3.24** -2.29 0.55 -4.17**  27.92 14.55  1.92 -0.93 0.39 -2.40* 
Notes. The number of subjects was 68 and the total number of observations was 521-551 in 
models of daytime mood/pain nighttime sleep. Models controlled age, gender, and pubertal 
status. Pain and mood variables were person-centered by subtracting each person’s mean rating 
from all of their daily ratings to represent within-person effects. Est = Estimate; WASO = Time 
Awake after Sleep Onset; Study Group is coded as 0 = SB and 1 = TD. 
*p < .05; **p < .01.  
 
Overview of Part II (Addressing Hypothesis 4) 
Part II of this project examined the relationship between sleep-wake disturbances and 
bio-neuropsychosocial functioning in adolescents with SB. Multivariate linear regression 
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analyses examined aggregated objective and subjective sleep variables as predictors of 
biopsychosocial functioning in the SB group only. Regression models included covariates and 
sleep variables that were significantly correlated with each measure of adolescent bio-
neuropsychosocial functioning as determined by bivariate correlation analyses. Variables 
included in each regression model are shown in Table 14.  
Correlations among covariates, sleep, and bio-neuropsychosocial variables 
Covariates and bio-neuropsychosocial variable (Tables 12 & 13).  Among the 
demographic covariates (Table 12), older adolescent age and more advanced pubertal status was 
associated with fewer symptoms of internalizing as reported by teachers (r = -.49 & r = -.55, 
respectively, ps < .05). More advanced pubertal status was also associated with fewer executive 
function problems as reported by teachers (r = .42, p = .02). Lower income level was associated 
with lower quality of life (r = .36, p = .03) and greater child report of internalizing symptoms (r 
= -.37, p = .03). Female gender was also associated with lower quality of life (r = -.48, p < .01).  
Regarding SB medical covariates (Table 13), the presence of a shunt and lower IQ were 
associated with more symptoms of internalizing as reported by teachers (r = .43 & r = -.58, 
respectively, ps < .05). Lower IQ was also related to greater symptoms of executive dysfunction 
as reported by parents (r = -.43, p = .02). Counterintuitively, the presence of a shunt was 
associated with less family conflict (r = -.35, p = .04) and greater family cohesion (r = .37, p = 
.03). Higher lesion level was associated with more frequent and intense pain (r = .40 & r = .36, 
ps < .05) and lower parent report of scholastic competence (r = -.40, p = .03). Higher number of 
prescription medication categories/types was also associated with more intense pain (r = .35, p = 
.04) and higher grades (r = .35, p = .04). Greater limitations in gross motor function was 
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associated with more frequent pain (r = .34, p = .04), lower health-related quality of life (r = -
.59, p < .01), and greater adolescent report of internalizing (r = .45, p = .01). 
Sleep-Wake disturbances and bio-neuropsychosocial functioning. Several significant 
associations were found among actigraphic sleep-wake variables and bio-neuropsychosocial 
functioning. Greater variability in total sleep time (sleep variability) was significantly related to 
greater child- and parent-report of internalizing symptoms (r = .42 and r = .53, ps < .05) and 
lower quality of life (r = .49, p < .01). Counterintuitively, longer total sleep time was associated 
with greater teacher-reported symptoms of internalizing (r = .44, p = .01) and greater WASO 
was associated with lower adolescent report of internalizing symptoms (r = -.34, p = .04). 
Further, longer total sleep time was also associated with greater family cohesion (r = .35 p = 
.04). Similarly, more minutes awake after sleep onset (WASO) and lower sleep efficiency were 
associated with greater family conflict (r = .36 & r = -.34, ps < .05). In terms of academic and 
neuropsychological functioning, unexpectedly, longer total sleep time was associated with 
greater teacher report of executive dysfunction (r = .41, p = .02) and lower parent-report of 
scholastic competence (r = -.39, p = .02).  
There were also several significant associations found among the subjective, 
questionnaire-reported sleep-wake variables and biopsychosocial variables. The total score of the 
Adolescent Sleep Hygiene Scale was the only sleep variable associated with physical 
functioning; poorer sleep habits was significantly correlated with higher zBMI (r = -.41, p = .02).
  
   
 
7
6
 
Table 12. Bivariate Correlations among Demographic and Bio-neuropsychosocial Variables in SB Group 
Variables 1     2     3    4    5     6    7    8    9 10 11 12 13 14 15 16 17 18 19 
1.   Gender
a
 --                     
2.   Age -.03 --                  
3.   Income Level
b
 -.25 -.01 --                    
4.   Pubertal Status .28 .52
*
 .21 --                 
5.   zBMI  .06 .26 -.14 .23 --               
6.   Pain Frequency 
(C) 
.18 -.21 -.14 .10 -.12 --              
7.   Pain Intensity 
(C) 
.11 -.10 -.18 -.11 -.10 .62
*
 --             
8.   PedsQL (M, F, 
C) 
.48
*
 -.07 .36
*
 -.05 -.16 -.41
*
 -.36
*
 --             
9.   Internalizing 
(M, F) 
.15 -.17 -.08 -.09 -.17 .22 .18 -.45
*
  --           
10. Internalizing
 
(T) .01 -.49
*
 -.27 -.55
*
 -.10 -.02 .14  .00 .05 --          
11. Internalizing
 
(C) .21 .06 -.37
*
 -.07 .17 .30 .22 -.76
*
 .29 .23 --         
12. Family Conflict 
(M, F) 
-.16 -.01 .03 -.19 -.01 -.05 -.08 .12 .08 -.01 -.03 --        
13. Family 
Cohesion (M, F) 
.17 .08 -.20 .14 -.04 .05 -.11 .10 -.28 .20 -.09 -.37
*
 --       
14. SNAP (M, F, T) -.07 .06 .07 -.14 .16 -.03 .05 -.33 .23 .21 .18 .24 -.23 --      
15. BRIEF (M, F) -.17 .20 .09  .07 .06 -.05 .02 -.38
*
 .55
*
 -.10 .20 .07 -.22 .71
*
 --     
16. BRIEF (T) .01 -.28 -.28 -.42
*
 .11 .09 .27 -.38
*
 .06 .64
*
 .32 .09 -.14 .69
*
 .25 --    
17. Harter-SC (M, 
F) 
.02 .06 -.01 .02 -.08 -.09 -.18 .44
*
 -.44
*
 -.31
*
 .39
*
 -.11 -.01 -.65
*
 -.68
*
 -.46
*
 --   
18. Harter-SC (T) -.07 .42
*
 .13 .24 -.02 -.04 -.28 .15 -.09 -.59
*
 -.06 -.11 .22 -.27 -.01 -.62
*
 .14 --  
19. Grades (M, F, 
T) 
.08 .16 .11 -.02 -.35
*
 .03 -.04 .27 -.09 -.34 -.18 -.06 .04 -.39
*
 -.23 -.42
*
 .36
*
 .54
*
 -- 
Notes. M = Mother-report; F = Father-report; C = Child-report; P = Combined parent-report; T = Teacher-report; zBMI = Body Mass 
Index z-score; PedsQL= Pediatric Quality of Life Inventory- Psychosocial Total Score; SNAP = Swanson, Nolan, and Pelham Teacher 
and Parent Rating Scale (Swanson et al., 2001) to measure inattention/hyperactivity; BRIEF = Behavioral Rating Inventory of 
Executive Function (Gioia, Isquith, Gray, & Kenworthy, 2000); Harter-SC = Harter Scholastic Competence scale.  
a
Gender coded as 0 = male, 1 = female 
bSpearman’s rho  
*p < .05 
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Table 13. Bivariate Correlations among Medical and Bio-neuropsychosocial Variables in SB Group 
Variables     1    2    3    4     5    6    7    8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
1.   Shunt Status
a 
--                       
2.   Lesion Level
b 
-.13 --                      
3.   Shunt Revisions
c 
 .52
*
 -.03 --                       
4.   Surgeries
c 
 .24 -.30 .27 --                    
5.   Hospitalizations
c 
 .06  .04 .17 .58
*
  --                    
6.   GMF   .08  .47
*
 .04 .06  .30 --                   
7.   Rx Medication
d 
 -.03  -.01 .23 .24  .34*  .10 --                 
8.   WASI  -.03 -.40
*
 .07 .22  .04 -.04  .04 --                
9.   zBMI  .08 -.17 .05 -.20 -.01 .07 .08 -.06 --               
10. Pain frequency (C) -.04 .39
*
 -.11 -.12 .14 .34
*
 .04 -.01 -.12 --              
11. Pain intensity (C) -.12 .36
*
 -.08 -.15 .13 .33 .35
*
 -.30 -.10 .62
*
 --             
12. PedsQL (M, F, C) -.04 -.26 .08 .07 -.13 -.59
*
 -.25 .09 -.16 -.41
*
 -.36
*
 --             
13. Internalizing (M, F) -.04 .32 -.06 .06 .06 .31 .03 -.01 -.17 .22 .18 -.45
*
  --           
14. Internalizing
 
(T) .43
*
 .27 .06 -.02 -.07 .10 -.25 -.58
*
 -.10 -.02 .14  .00 .05 --          
15. Internalizing
 
(C) .02 .32 -.19 -.09 .11 .45
*
 .16 -.16 .17 .30 .22 -.76
*
 .29 .23 --         
16. Family conflict (M, F) -.35
*
 .10 -.13 -.07 -.10 -.08 -.14 .01 -.01 -.05 -.08 .12 .08 -.01 -.03 --        
17. Family cohesion (M, F) .37
*
 .16 .15 -.33 -.32 -.05 -.20 -.02 -.04 .05 -.11 .10 -.28 .20 -.09 -.37
*
 --       
18. SNAP (M, F, T) .22 -.04 .28 .22 .03 .10 .16 -.09 .16 -.03 .05 -.33 .23 .21 .18 .24 -.23 --      
19. BRIEF (M, F) .31 -.03 .02 .09 .08 .25 .11 -.43
*
 .11 -.05 .02 -.38
*
 .55
*
 -.10 .20 .07 -.22 .71
*
 --     
20. BRIEF (T) .11 .08 .20 .12 -.13 .08 .09 .09 .06 .09 .27 -.38
*
 .06 .64
*
 .32 .09 -.14 .69
*
 .25 --    
21. Harter-SC (M, F) -.15 -.40
*
 -.24 -.09 -.11 -.32 -.19 .21 -.08 -.09 -.18 .44
*
 -.44
*
 -.31
*
 -.39
*
 -.11 -.01 -.65
*
 -.68
*
 -.46
*
 --   
22. Harter-SC (T) -.13 .10 .07 .12 .02 -.09 .32 .36 -.02 -.04 -.28 .15 -.09 -.59
*
 -.06 -.11 .22 -.27 -.01 -.62
*
 .14 --  
23. Grades (M, F, T) -.12 .07 .06 .01 -.13 -.27 .35* .11 -.35
*
 .03 -.04 .27 -.09 -.34 -.18 -.06 .04 -.39
*
 -.23 -.42
*
 .36
*
 .54
*
 -- 
Notes. GMF = Gross motor functioning (higher scores indicate higher level of impairment); WASI = Wechsler Abbreviated Scale of 
Intelligence; zBMI = Body Mass Index z-score; PedsQL= Pediatric Quality of Life Inventory- Psychosocial Total Score; SNAP = Swanson, 
Nolan, and Pelham Teacher and Parent Rating Scale to measure inattention/hyperactivity; BRIEF = Behavioral Rating Inventory of Executive 
Function; Harter-SC = Harter Scholastic Competence scale.  
a
Shunt status coded as 1 = present; 0 = absent/no shunt 
b
Lesion level coded such that sacral lesions levels had lowest scores and thoracic had highest scores 
c
Total number; Shunt revisions are total in lifetime, surgeries and hospitalizations are total in previous two years  
d
Rx medications represent the total number of types of prescription medications taken (e.g., antidepressants, anticonvulsants, etc.) 
*p < .05; **p < .01 
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In terms of psychosocial functioning, worse sleep quality, poorer sleep habits, higher 
levels of pre-sleep arousal, and greater daytime fatigue were associated with more symptoms of 
internalizing as reported by adolescents (rs = -.59 - .54, ps < .05) and lower psychosocial health-
related quality of life (rs = -.54 - .76, ps < .05). Sleepiness was associated with greater parent 
report of youths’ internalizing (r = .44, p = .01) and lower psychosocial quality of life (r = -.36, p 
= .03).  
With regard to neuropsychological and academic functioning, fatigue and sleepiness were 
associated with greater executive function problems as reported by teachers and parents, 
respectively (r = -.44 & r = .39; ps < .05). The sleepiness subscale was also associated with 
greater symptoms inattention/hyperactivity (r = .36, p = .04) and lower parent-report scholastic 
competence (r = .39 p = .02).  Finally, greater fatigue and sleepiness was associated with lower 
school grades (r = .39 & r = -.41, ps < .05). 
None of the objective or subjective sleep variables were significantly associated with pain 
frequency or intensity. The PSQ snoring subscale was not significantly related to any of the bio-
neuropsychosocial outcomes (ps > .05).  
Multivariate regression analyses: sleep-wake disturbances as predictors of bio-
neuropsychosocial functioning in adolescents with SB (Hypothesis 4). Results of multivariate 
regression analyses predicting physical functioning after controlling for relevant covariates are 
presented in Table 14. 
Physical functioning. Worse sleep habits were identified as the only significant predictor 
of increased body mass index (BMI) in adolescents with SB (β = −.38, p = .02). Subjective and 
objective sleep disturbances were not associated with pain frequency or intensity in adolescents 
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with SB. While higher lesion level did not significantly predict higher pain intensity using the 
standard alpha level of less than .05, the p-value was exactly .05 (β = .36) and therefore closely 
approached significance.   
Because recent research has increasingly highlighted the impact of sleep timing (i.e., later 
bedtime/wake times) as a salient predictor of pediatric obesity (Horne, 2008), we sought to 
further explore the specific domains of the Adolescent Sleep Habits Questionnaire (ASHS) that 
may predict greater zBMI in our sample of adolescents with SB. Specifically, the four subscales 
of the ASHS (Cognitive, Emotional, Sleep Environment, and Sleep Stability) were entered into 
the regression model predicting zBMI in forward fashion. Results indicated that lower scores on 
the Sleep Stability subscale (including 4 items related to going to bed and waking up late on the 
weekends and weekdays) predicted zBMI (r = -.25, p =.04). Thus, greater sleep timing instability 
(going to bed late/sleeping in during the week) was related to higher zBMI in adolescents. 
Psychological functioning.  As hypothesized, poorer self-report of sleep quality and 
greater actigraphic sleep variability predicted lower psychosocial quality of life in our sample of 
adolescents with SB (β = .51& β = −.28, respectively, ps < .05). Greater sleep variability and 
sleepiness predicted greater internalizing symptoms as measured by parent report (β = .53 & 
β = .31, ps < .05). In addition, sleep variability and greater pre-sleep arousal emerged as a 
significant predictors of adolescent report of internalizing symptoms (β = .33 & β = .48, ps < 
.05).  
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Table 14. Objective and Subjective Sleep Predicting Bio-neuropsychosocial Functioning in 
Adolescents with SB 
Dependent Variables Independent Variables b SE b β 
Physical Functioning     
Body Mass Index (BMI) Sleep Habits -0.72  0.31 -0.38* 
Pain frequency (C) None Significant -- -- -- 
Pain intensity (C) Lesion Level
a 
 1.85  0.91  0.36+ 
Psychological Functioning     
PedsQL Psychosocial Total  
(M, F, C) 
Gender
b 
Gross Motor Function 
Sleep Variability (A) 
Sleep Quality (Q) 
-10.05 
-6.48 
-0.45 
 9.34 
 3.44 
 1.63 
 0.20 
 2.14 
-0.38** 
-0.51** 
-0.28* 
 0.50** 
Internalizing (M, F) Sleep Variability (A) 
Sleepiness (Q) 
 0.57 
 9.46 
 0.16 
 4.41 
 0.53** 
 0.31* 
Internalizing
 
(T) 
 
 
 
Age 
Pubertal Status 
Shunt Status
c 
IQ
d 
-2.79 
-5.52 
 9.55 
-0.30 
 0.97 
 2.63 
 2.91 
 0.06 
-0.34** 
-0.25* 
 0.34** 
-0.55** 
Internalizing
 
(C) Gross Motor Function 
Sleep Variability (A) 
Pre-sleep Arousal (Q) 
 0.10 
 0.01 
 0.74 
 0.04 
 0.01 
 0.21 
 0.45** 
 0.33* 
 0.48** 
Family Functioning     
Family conflict (M, F) Shunt Status
c 
WASO (A) 
-0.34 
 0.05 
 0.16 
 0.02 
-0.35* 
 0.34* 
Family cohesion (M, F) Shunt Status
c 
 0.29  0.13  0.37* 
Neuropsychological Functioning    
Inattention/Hyperactivity
e
(M, F, T) Sleepiness (Q)  0.43  0.21  0.34* 
Executive Dysfunction
f
 (M, F) Sleepiness (Q)  0.43  0.17  0.41* 
Executive Dysfunction
f
 (T) Pubertal Status 
IQ
d 
Fatigue (Q)
h 
-0.23 
-0.01 
-0.01 
 0.11 
 0.01 
 0.01 
-0.35* 
-0.37* 
-0.41* 
Academic Functioning     
Scholastic Competence
g
 (M, F) Lesion Level
a 
-0.42 0.18 -0.40* 
Scholastic Competence
g
 (T) Age  0.23 0.10 0.42* 
Grades (M, F, T) # Rx Medication Types 
Fatigue (Q) 
 0.54 
 0.04 
0.26 
0.01 
0.35* 
0.47** 
Notes. Regression models were trimmed such that non-significant (p > .05) were effects 
removed). M = Mother-report; F = Father-report; C = Child-report; P = Combined parent-report; 
T = Teacher-report; A = Actigraphy/Objective Sleep Variable; Q = Questionnaire/Subjective 
Sleep Variable; BMI = Body Mass Index z-score; WASO = minutes awake after sleep onset; 
Sleep Variability = average variation in Total Sleep Time.  
a
Coded such that sacral lesions levels had lowest scores and thoracic had highest scores;  
b
Coded as 0 = male, 1 = female;  
c
Coded as 1 = shunt present; 0 = absent/no shunt;  
d
Measured with the Wechsler Abbreviated Scale of Intelligence (WASI);  
e
Measured with Swanson, Nolan, and Pelham Teacher and Parent Rating Scale (SNAP); 
f
Measured with the Behavioral Rating Inventory of Executive Function (BRIEF). 
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g
Measured with the Harter- Scholastic Competence Scale. 
h
Measured using the PedsQL Multidimensional Fatigue Scale, lower scores indicate greater 
problems with fatigue.
 
*p < .05, **p < .01 
 
Sleep-wake disturbances did not predict teacher report of adolescent internalizing after 
adjusting for covariates. Younger age, less advanced pubertal status, lower IQ, and presence of a 
shunt were significantly related to greater teacher-report of internalizing symptoms (βs = -.55 - 
.34, ps < .05). In addition, greater (i.e., more limited) gross motor function and female gender 
predicted lower quality of life (β = -.51 & β = -.38, ps < .05). More limited gross motor function 
also predicted more internalizing symptoms as reported by adolescents (β = .48 p = .01).  
Family functioning. WASO emerged as the only significant sleep predictor of family 
functioning. As hypothesized, more minutes awake after sleep onset (WASO) predicted greater 
family conflict (β = .34, p = .04). Counterintuitively, the presence of a shunt predicted lower 
family conflict (β = -.35, p = .04) and greater family cohesion (β = .37, p = .03) in our sample. 
 Neuropsychological functioning. Parent report of adolescent sleepiness emerged as a 
significant predictor of inattention/hyperactivity (β = .34, p = .04) and parent-report of executive 
dysfunction (β = -.41, p = .04). Similarly, greater levels of fatigue were associated with greater 
executive dysfunction as reported by teachers (β = .40, p = .01). Less advanced pubertal status 
and lower IQ were also associated with greater problems with teacher-reported executive 
dysfunction (β = -.37 & β = -.37, ps < .05). 
 Academic functioning. Fatigue emerged as the only significant predictor of academic 
functioning; greater fatigue was associated with lower school grades in adolescents with SB (β 
= .47, p = .004). Sleep-wake disturbances did not predict scholastic competence. In terms of 
covariates, older age and lower lesion level were associated with better teacher- and parent- 
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report of scholastic competence, respectively (β = .42 & β = -.40, ps < .05). More types of 
prescription medication were associated with higher school grades (β = .35, p = .04). 
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DISCUSSION 
Sleep Disturbances in Adolescents with Spina Bifida 
This study is the first to provide a case-controlled, multi-modal assessment of sleep-wake 
disturbances in pediatric SB using objective and subjective sleep instruments. Overall, study 
findings suggest that adolescents with SB experience higher rates of sleep-wake disturbances 
across actigraphy and questionnaire measures compared to typically developing youth. 
Adolescents with SB were found to experience sleep deficits, more time awake after sleep onset, 
lower sleep efficiency, and greater sleep variability (inter-individual variation in sleep time) 
according to actigraphy and reported worse sleep quality, sleep habits, and higher levels of 
fatigue on questionnaire measures.  
Our findings that adolescents with SB reported worse objectively and subjectively-
measured sleep is consistent with prior research on sleep patterns among youth with chronic 
illnesses, developmental and physical disabilities, and neurological conditions (Hysing et al., 
2009; Tham, Fales, & Palermo, 2015; Tieze et al., 2012). Notably, our data confirmed that 
adolescents with SB received slightly less total sleep compared to their peers. In particular, 
adolescents with SB slept a little over 6 hours, with typically developing youth receiving slightly 
more sleep (about 6 ½ hours) on average. Given National Sleep Foundation recommendations 
that adolescents should obtain between 8-10 hours of sleep for optimal daytime functioning 
(National Sleep Foundation, 2015), these results confirm the presence of significant sleep deficits 
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in adolescents with SB. Sleep deficits in this population are likely due to disrupted sleep 
continuity, as indicated by actigraphic results of greater time awake after sleep onset (WASO) 
and poorer sleep efficiency.  
Subjective reports of sleep-wake disturbances substantiated actigraphy data on poor sleep 
continuity. In particular, this is the first study to highlight the presence of insomnia symptoms in 
pediatric SB. About one quarter (25.7%) of adolescents with SB reported clinically significant 
difficulties staying asleep (i.e., 60% or more of the time) compared to 8.1% of TD youth.  
Consistent with the typical clinical presentation of pediatric insomnia, the largest effect sizes for 
group comparisons on the sleep quality subscales were found for difficulties going to bed and 
reinitiating sleep (Meltzer & Crabtree, 2015). Difficulties with bedtime settling and staying sleep 
often co-occur, as adolescents that cannot easily settle to sleep may also be less likely to re-settle 
themselves after awakening during the night.  
Results of this study also highlight the presence of more problematic bedtime sleep habits 
in adolescents with SB compared to the TD sample. In addition, adolescents with SB 
experienced more sleep variability (often referred to as night-to-night stability in sleep 
time/quantity) compared to their peers. As we found in our preliminary analyses, poorer bedtime 
habits are often associated with greater sleep variability (Becker et al., 2016). For adolescents 
with SB, less optimal sleep environments (e.g., noise, TV watching) and more disruptive/chaotic 
schedules (e.g., time spent in hospital settings/away from home) may impact the stability of 
night-to-night sleep time. It will be critical for clinicians working with adolescents with SB and 
their caregivers should not only inquire about overall or average sleep quantity, but also the 
stability of sleep quantity, as well as barriers to establishing consistent sleep schedules. 
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Efficacious preventative and treatment efforts may focus on promoting better sleep habits 
(Melzer & Crabtree, 2015) including the improvement of physical sleep environments (reduced 
electronics use, and cool, dark sleep environments) and establishing consistent bedtimes and 
wake times to stabilize sleep patterns in adolescents with SB.  
Finally, levels of fatigue were alarmingly high in adolescents with SB compared to their 
TD peers. In fact, severity levels were similar to those reported by children and adolescents 
undergoing active treatment and chemotherapy for cancer (Erickson et al., 2011; Varni et al., 
2002). Clinicians and parents commonly attribute fatigue to underlying disease-related 
mechanisms such as pain and weakness; indeed, significant associations between gross motor 
limitations and fatigue may implicate muscle weakness in the development of fatigue in pediatric 
SB. Intuitively, sleep disturbances may contribute to the development of fatigue in adolescents 
with and without chronic illnesses (Tham, Holley, Zhou, Clarke, & Palermo, 2013). Indeed, our 
preliminary analyses found that questionnaire-reported sleep quality and pre-sleep arousal were 
strongly correlated with fatigue in adolescents with SB (i.e., rs ≥ .70), with less robust 
associations found for TD adolescents (i.e., moderate rs = .50 -.69). Further research is needed to 
understand the role of nighttime sleep disturbances and other psychosocial factors (e.g., 
depression) on the development and persistence of fatigue in youth with SB. Fatigue represents a 
significant clinical problem in adolescents with SB, and such work may help to identify salient 
treatment targets to prevent or ameliorate these symptoms. 
While the majority of group comparison results showed that adolescents with SB are at-
risk for sleep disturbances, descriptive analyses of diary-reported sleep quality found that the SB 
sample endorsed better sleep quality compared to TD adolescents. Although counterintuitive, 
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these findings may be partially attributed to the chronicity of sleep problems and co-morbidities 
in this condition; more positive ratings of sleep quality may reflect an adaption process to 
undetected, unremitting sleep difficulties rather than lack of sleep disruptions. In other words, it 
is possible that some adolescents with SB have not yet experienced a reprieve from sleep 
disturbances and, thus, do not perceive “good” sleep quality in the same way as their TD peers. It 
is also possible that adolescents with SB are less likely to notice daily fluctuations in sleep 
quality because noticeable behavioral and neuropsychological symptoms of poor sleep quality, 
such as inattention, may be misattributed or masked by underlying neuropsychological 
vulnerabilities present since birth. Clearly, a one-item rating of global sleep quality is not 
sufficient to identify sleep disturbances in youth with SB. In clinical and research settings, a 
comprehensive assessment of sleep-wake patterns may be critical to improve identification and 
treatment of sleep disturbances in adolescents with SB. 
Associations between Sleep Disturbances and Bio-neuropsychosocial Functioning 
Sleep is a critical developmental need for adolescents, and when disrupted, has been 
linked to a multitude of issues with physical status, psychological health, family functioning, 
neuropsychological symptoms, and academic performance (Alfano, Zakem, Costa, Taylor & 
Weems, 2009; Chen, Beydoun & Wang, 2008; Kheriandish & Gozal, 2006). Because 
adolescents with SB are already at-risk for difficulties in these areas (Appleton, 1997; Clancy, 
McGrath, & Oddson, Holmbeck et al., 2003; Holmbeck et al., 2010; Rose & Holmbeck, 2007), 
good sleep quantity and quality may be especially critical. Yet there are limited data to date on 
how sleep disturbances relate to key areas of health and functioning in this population. 
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As a first step toward understanding potential consequences of sleep disturbances in 
adolescents with SB, our study examined bio-neuropsychosocial correlates of sleep disturbances 
in this at-risk population. As part of a 10-day sleep assessment procedure, we collected daily 
actigraphy and diary information to examine temporal relationships between sleep, mood, and 
pain in the SB and comparison groups. We also identified associations between sleep and a 
broader array of adolescent physical, psychosocial, family, neuropsychological, and academic 
functioning in the SB group only. Overall, study findings indicated that sleep-wake disturbances 
were associated with every domain of adolescent functioning within the bio-neuropsychosocial 
model. Most consistently, our results uncovered associations between objective and subjective 
nighttime sleep disturbance and psychological maladjustment (internalizing, HRQOL). To a 
lesser extent, nighttime sleep disturbances were linked to worse physical health (pain, BMI) and 
family functioning (family conflict). Furthermore, daytime sleepiness and/or fatigue, but not 
nighttime sleep disturbances, was associated with worse neuropsychological and academic 
functioning, including inattention/hyperactivity, executive dysfunction, and lower school grades. 
For children and adolescents with SB, good sleep quality and quantity have far-reaching effects 
and may be critical to optimizing multiple aspects of health and well-being.  
Sleep and Physical Functioning 
Research on sleep and physical health has tended to focus on two important physical 
health parameters: pain and weight status/obesity. Similar to investigations of daily sleep-pain 
associations in children with JIA (Bromberg, Gil, & Schanberg, 2012) and adolescents with 
idiopathic chronic pain (Lewandowski, Palermo, De la Motte et al., 2010), pain intensity did not 
impact sleep disturbances, but more minutes awake after sleep onset (WASO) predicted higher 
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pain intensity the following day in adolescents with and without SB. It is possible that sleep 
disturbances may be a stronger predictor of pain than pain is of sleep disturbances. Experimental 
sleep modification research showing that sleep deprivation causes increased pain sensitivity and 
hyperalgesic pain response supports this notion (Lautenbacher, Kundermann & Krieg, 2006). 
Because overall levels of pain reported by adolescents with and without SB were low, it is also 
possible that pain was not severe enough to disrupt nighttime sleep. However, comparing our 
data with previous reports on young adults with SB suggests that pain may become more severe 
and frequent as individuals with this condition approach adulthood (Verhoef et al., 2004), 
potentially due to increases in secondary medical complications (e.g., shunt malfunctions) and 
surgical procedures. Interventions targeted toward sleep in this population may be effective at 
reducing sleep disturbances while also reducing pain intensity and, quite possibly, lowering the 
risk for developing chronic pain later in adulthood.  
In addition to chronic pain, individuals with SB are also at-risk for obesity and 
overweight. Our study found that poorer sleep habits were associated with higher zBMI in 
adolescents with SB. This finding was somewhat surprising given the number of studies that 
have supported associations between total sleep time and pediatric obesity (Cappuccio et al., 
2008; Marshall et al., 2008). On the other hand, recent research has revealed that late sleep 
timing (i.e., later bedtimes or wake times) may be a better predictor of pediatric obesity than total 
sleep time (Horne, 2008) per say. Indeed, our exploratory regression analyses found that later 
sleep timing (going to bed late, sleeping in) was driving this relationship. Later sleep timing 
behavior may provide more opportunities for adolescents with SB to engage in sedentary 
behaviors (e.g., TV watching) and nighttime snacking/overeating (Golly, Maher, Mattriciani, & 
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Olds, 2013). Health professionals working with adolescents with SB on issues pertaining to sleep 
and eating behavior should consider assessing typical bedtimes and wake times. Interventions 
and experimental home-based sleep extension protocols have successfully modified bedtimes 
(and extended sleep) in adolescents with asthma and T1DM (Meltzer, Faino, Szefler, Strand, 
Geldand, & Beebe, 2015; Perfect, Beebe, Levine-Donnerstein, Frye, Bluez, & Quan, 2016), with 
observed positive effects on physical health outcomes. Similar research may be conducted in 
adolescents with SB to provide useful data on sleep timing as a treatment target for improved 
physical health 
Sleep and Psychological Functioning 
The current study also suggests that nighttime sleep patterns and behaviors are strongly 
related to adolescent psychological dysfunction. In support of a small but growing number of 
studies on the adverse psychosocial consequences of sleep variability (Bei Bei, Wiley, Trinder, 
Manber, 2016; Becker, Sidol, Van Dyk, Epstein, & Beebe, 2016), greater sleep variability was 
associated with poorer psychological well-being in adolescents with SB (internalizing, 
psychosocial HRQOL). While pediatric sleep is often measured across several days, previous 
studies have not systematically investigated night-to-night variability in sleep (Bei Bei, Wiley, 
Trinder, Manber, 2016). There is also a lack of existing framework for understanding the 
mechanisms through which sleep variability is associated with psychological functioning. 
Potentially, sleep variability may play a role in mood instability and difficulties coping with 
fluctuations in negative arousal. To better understand the nature and impact of sleep variability, 
there is an overarching need for clinical and research efforts to address both typical and night-to-
night variation in sleep time. Working with parents to establish consistent bedtimes may improve 
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sleep and co-morbid internalizing symptoms in adolescents with SB. From a preventative 
standpoint, bedtime habits may be established early in childhood and monitored throughout 
development.  
Further, our study results found that heightened pre-sleep arousal and daytime sleepiness 
was associated with internalizing symptoms in adolescents with SB. Cognitive and physiological 
arousal at bedtime may perpetuate or maintain negative sleep patterns (Palermo, Law, Churchill, 
& Walker, 2012), placing youth at-risk for developing depression. Dysfunctional cognitions 
about sleep and the daytime consequences of poor sleep are common in those experiencing 
difficulties initiating sleep (i.e., cognitive pre-sleep arousal), and this type of ruminative thinking 
style may be reinforced over time, further perpetuate sleep disturbance, and lead to the 
development or intensification of depression symptoms (Lovato & Gradisar, 2015). Daytime 
sleepiness may further intensify depressive symptoms by reducing adolescents’ motivation to 
partake in social activities (Lovato & Gradisar, 2015). It will be important for longitudinal 
research to expand data on the temporal sequence of sleep and internalizing symptoms in 
vulnerable child and adolescent populations such as SB. Such work may test complex 
longitudinal pathways and include modifiable behavioral mechanisms (i.e., pre-sleep arousal) 
through which sleep confers risk for psychosocial maladjustment.  
In support of these cross-sectional data, daily analyses found that poorer sleep efficiency, 
reduced total sleep time, and lower diary-reported sleep quality predicted worse next-day mood 
in our adolescent samples. These findings are unsurprising given growing evidence of the role of 
sleep in developing affective disorders such as depression in adolescents (Ivanko, 2015). Sleep 
has been implicated in the regulation of emotional brain networks, including facilitation of 
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inhibitory effects of the medial-prefrontal amygdala (Walker & van der Helm, 2009). Sleep 
difficulties may therefore disrupt emotional regulation processes and, if chronic, may lead to 
more frequent and intense symptoms of depression and anxiety (Ivanko, 2015).  
Results of multilevel models on sleep predicting next-day pain and mood suggest that 
sleep disturbances may represent a common risk factor for internalizing and pain symptoms in 
pediatric SB. Thus, interventions that target sleep may lead to improvements in both pain and 
mood. It will also be important for future work to discern the temporal sequence of sleep, pain, 
and internalizing symptoms- deemed the “Unhappy Triad” (Koffel, Krebs, Arbisi, Erbes, & 
Polusny, 2016). Research on adult populations suggests that the temporal link between sleep and 
pain may be due, in part, to negative mood (Koffel et al., 2016). In other words, sleep disruptions 
may result in emotional dysregulation and impaired mood, which can impact pain perception and 
pain-related distress through increased physiologic or cognitive arousal. On the other hand, pain 
may also mediate the sleep-internalizing relationship, such that disrupted sleep reduces pain 
thresholds, directly resulting in increased pain severity, and ultimately increased negative 
cognitions and emotions (Koffel et al., 2016). Testing competing longitudinal models 
encompassing this symptom triad should be applied to pediatric populations including SB to 
broaden our understanding of the etiology and temporal unfolding of sleep, pain, and mood. s 
may increase susceptibility to psychological disorders such as anxiety and depression.   
Finally, and counterintuitively, positive daytime mood predicted reduced total sleep time 
and lower diary-reported sleep quality. Thus, the daily dynamics of sleep and mood may be more 
complexly related than previously theorized. It is possible that typical adolescent activities 
associated with positive mood, such as socializing with friends, delay sleep onset and thereby 
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reduce sleep quantity and quality (Fuligni & Hardway, 2006). Additionally, while our study did 
not measure different types of positive and negative affect, certain emotions may be 
characterized by higher levels of cognitive and physiological arousal (e.g., excitement vs. calm) 
that are non-conducive to sleep. Furthermore, our study was limited to measuring mood once 
daily (in the morning). Future studies may utilize techniques such as electronic momentary 
assessment to capture fluctuations in mood throughout the day and prior to bed, along with co-
occurring activities (e.g., studying, social/extra-curricular activities), to better understand the 
complex relations between mood, activities, and sleep in adolescents with and without chronic 
medical illnesses.  
Sleep and Family Functioning 
Consistent with previous research (Kelly & El-Sheikh, 2011), adolescent sleep 
disturbances were linked to family dysfunction. Specifically, more wake time after sleep onset 
(WASO) was associated with greater parent-reported family conflict. There are several possible 
explanations for why adolescent sleep disturbances may be associated with family conflict. Sleep 
disturbances may contribute to adolescent psychological maladjustment, resulting in negative 
and stressful parent-child and marital interactions (Kelly & El-Sheikh, 2011). Particularly for 
youth with chronic health conditions, sleep disturbances could also compromise parents’ sleep 
(Meltzer & Mindell, 2007), which can impact parental psychological functioning (Bayer, 
Hiscock, Hampton, & Wake, 2007) and increase the likelihood of conflict (Kelly & El-Sheikh, 
2011). Many parents of youth with SB continue to be involved in several aspects of medical 
management into late adolescence (Psihogios, Kolbuck, & Holmbeck, 2015). Thus, adolescent 
and parent dyads may experience poor sleep quality as a result of parent-assisted nighttime 
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medical management behaviors that disrupt sleep, such as catheterization management. 
Examining adolescent and parental psychological maladjustment as mediators of the sleep-
family conflict relation will be an important next step towards understanding these processes.  
Importantly, emerging evidence has broadened our understanding of reciprocal 
associations between sleep and family functioning. Just as adolescent sleep may impact family 
conflict, conflict may disrupt sleep (Kelly & El-Sheikh, 2011). Family conflict is broadly linked 
to higher perceived vulnerability and environmental stress (Jarrin, McGrath, & Quon, 2014), 
which may heighten cognitive and physiological arousal and disrupt sleep continuity. These 
processes may also exist in a cyclical pattern; exposure to conflict may lead to sleep disruptions 
which may, in turn, lead to increased family conflict. Previous research and current study 
findings highlight the importance of multimodal, longitudinal sleep research that examines 
reciprocal relations between sleep and family/parent functioning in the context of pediatric SB.  
Sleep and Neuropsychological and Academic Functioning 
While the origins of poor neuropsychological skills in pediatric SB are not fully 
understood, our study findings indicate that executive dysfunction and symptoms of 
inattention/hyperactivity may be partially attributed to daytime sleepiness. Higher levels of 
fatigue were also associated with executive dysfunction and lower school grades. These findings 
support a growing number of studies that have found that daytime sleepiness and fatigue, but not 
sleep quantity, may lead to decrements in neuropsychological and academic functioning 
(Anderson et al, 2009; Dewald et al., 2010). Overall, sleepiness and fatigue may have a more 
proximal influence on neuropsychological and school functioning than sleep disturbances per 
say. While insufficient or poor sleep quality may cause daytime sleepiness, reductions in 
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cognitive alertness may directly impair executive function, attention, and learning capacity 
(Dewald et al., 2010).  
Moreover, inattention, executive dysfunction, and poor academic performance has been 
well documented in pediatric sleep disorders characterized by sleep fragmentation (i.e., increased 
night awakenings) and daytime sleepiness, including sleep disordered breathing (SDB) and 
delayed sleep phrase syndrome (Beebe et al., 2004; Giannotti, Cortesi, Sebastiani, & Ottaviano, 
2002; Blunden, Lushington, Kennedy, Martin, & Dawson, 2000; Cortese et al., 2005). Youth 
with SB are at-risk for physiological sleep disorders such as central and obstructive sleep 
disordered breathing (SDB; Waters et al., 1998; Kirk, Morielli & Brouillette 1999). Indeed, 
symptoms suggestive of SDB were found in one fifth (21.6%) of our SB sample, which is several 
times the prevalence found in large community samples of adolescents (e.g., 6.0%; Johnson & 
Roth, 2006). From a developmental psychopathology perspective, sleep disturbances and 
daytime sleepiness are also common in youth with ADHD (Chervin, Dillon, Bassetti, Ganoczy, 
& Pituch, 1997; Cortese, Konofal, Yateman, Mouren, & Lecendreaux, 2006; Gau & Chiang, 
2009), and children and adolescents with SB have higher rates of ADHD-inattentive type 
compared to their peers (Burmeister et al., 2005). Thus, sleepiness or fatigue and other associated 
cognitive and academic impairments may be the result of underlying sleep or psychiatric 
diagnoses (ADHD, MDD) that were not assessed in the current study. 
Limitations and Future Directions 
 The current study has a number of strengths, such as utilizing a multimodal sleep 
assessment (questionnaires, actigraphy, diary), multiple reporters of adolescent functioning 
(youth-, mother-, father-, and teacher- report), and a comparison group. However, there are 
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several limitations of this study that can be addressed in future work. As is common in pediatric 
samples, our sample size was small. This limited our statistical power, particularly for single-
group analyses involving SB adolescents only. The negative sequelae of sleep may be 
compounded in adolescents with SB given their increased vulnerability to poor bio-
neuropsychosocial outcomes secondary to their illness. Yet, because this study utilized a 
comparison group from a separate NIH-funded adolescent sleep study that had already 
completed study procedures, we could not administer bio-neuropsychosocial measures to the 
control group and test for the potential moderating effect of group (i.e., SB vs. TD groups) on 
sleep-functioning associations. On the other hand, our use of hierarchical linear modeling of 
daily sleep, pain, and mood allowed for increased power to detect within-individual variations in 
sleep-pain and sleep-mood associations. Previous work has also found greater sleep disturbances 
in minority compared with Caucasian children and families of lower socioeconomic status 
(Roberts, Roberts, & Chen, 2000). However, our sample was composed of predominately 
Caucasian (70%) and middle-income families, which limits the generalizability of study 
findings. At the same time, there was an extra effort to recruit Hispanic, Spanish-speaking 
families due to the higher incidence of SB in this ethnic group. Recruitment efforts resulted in a 
higher percentage of Hispanic families (21.6%), which better reflect the ethnic composition of 
pediatric SB. Further, researchers have advocated for specifying multiple indices of 
socioecological risk factors of sleep in children, such as community-level poverty (El-Sheikh et 
al., 2013). Yet, our study was limited to assessment of family income level and could not 
determine socioeconomic risk factors for sleep disturbances.   
Various physiological and psychosocial mechanisms may help to explain the 
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development of nighttime sleep disruptions in adolescents with SB. However, pediatric SB is 
characterized by significant medical heterogeneity, which may explain why our study found 
limited support for condition-related risk factors. Sleep disruptions may be associated with 
physiological alterations of this condition, including respiratory impairments that increase the 
likelihood of SDB. Additionally, greater limitations in gross motor functioning were associated 
with higher levels of daytime fatigue, which may implicate muscle weakness in the development 
or persistence of fatigue in this population. Future research should examine other salient 
condition characteristics that were not assessed in the current study, including discomfort related 
to spasticity and constipation, nighttime enuresis, neurological characteristics (e.g., Chiari 
malformation), and the presence of comorbid sleep disorders (i.e., periodic limb movement) and 
medical conditions (e.g., epilepsy, asthma).  
Moreover, it is likely that sleep and medical illness exist in a bidirectional relationship; 
while various aspects of a chronic illness may affect sleep, sleep disturbances may also 
exacerbate a chronic illness and disease-related symptomatology (Lewandowski et al., 2011b). In 
particular, it will be beneficial to identify specific medical management behaviors that may 
disrupt sleep in this population, such as nighttime catheterization and bed turning. Likewise, 
effective management of SB requires daily use of neuropsychological and emotional processes 
(e.g., decision-making, motivation, planning, memory) that may be significantly impaired by 
poor sleep quality and daytime sleepiness (Dewald, Meijer, Oort, Kerkhof, & Bögels, 2010; 
Perfect et al., 2014; Steenari et al., 2003). Future research may investigate whether sleep-wake 
disturbances exacerbate cognitive and emotional dysfunction with consequential impediments in 
youths’ ability to perform the often complex array of medical management behaviors.   
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Our study also had limitations in measurement and design. While actigraphy and self-
reports are important tools for assessing sleep-wake patterns in adolescents, the gold standard for 
quantifying sleep is polysomnography (PSG). Actigraphy is often used in studies due to its 
comparatively low cost and ecological validity in the home environment compared to PSG. Still, 
future work may use PSG to expand our understanding of sleep in adolescents with SB, 
including the incidence of undetected physiological sleep disorders. Finally, we used parent- and 
teacher- questionnaire report of inattention/hyperactivity and executive dysfunction. 
Questionnaire measures of neuropsychological functioning have the advantage of assessing 
“real-world” functioning, and attention and executive functioning are often difficult to assess in a 
testing environment (Beebe, 2011). However, performance-based measures of 
neuropsychological functioning may reduce common method variance and parse out specific 
cognitive deficits related to sleep (Beebe, 2011).   
Finally, the cross-sectional nature of this study presents a major limitation in 
understanding the direction of associations sleep and adjustment in adolescents with SB. There is 
limited longitudinal data on sleep in SB and other pediatric populations. Our previous work 
employed longitudinal growth modeling to understand trajectories of sleep disturbances in 
children and adolescents with SB, yet utilized a limited measure of sleep disturbances drawn 
from a behavioral screening tool (the CBCL; Murray et al., 2015). Future longitudinal research 
may examine trajectories, predictors, and consequences of sleep-wake disturbances using multi-
wave, multi-modal sleep assessments. Further, conducting sleep interventions and experimental 
sleep extension trials may increase our understanding of the mechanisms and consequences of 
poor sleep in this vulnerable medical condition.  
98 
 
   
 
Clinical Implications and Conclusions 
 Despite limitations, the results of this study have important clinical implications. 
Unfortunately, sleep disturbances in children with developmental and physical disabilities often 
go unrecognized in clinical settings (Mindell & Owens, 2003). Extending the limited data on 
sleep disturbances in individuals with SB, results of our study suggest that adolescents with SB 
are at-risk for significant nighttime sleep disturbances and fatigue that require early assessment 
and management. This finding is clinically important given evidence that sleep disturbances may 
persist or recur over time (Morrison, McGee, & Stanton, 1992; Roberts et al., 2008) and are 
connected to adverse outcomes highly relevant to individuals with SB (e.g., BMI, executive 
dysfunction). Early assessment and prevention efforts may be critical to prevent long-term sleep 
problems and optimize health and well-being in this population.  
Currently, sleep disturbances among adolescents with SB may be under-identified and 
undertreated. Given the gap in literature on sleep in pediatric SB, parents and health 
professionals may be more likely to attend to other salient aspects of SB management (e.g., 
adherence to a complex medical regimen), and inadvertently neglect to discuss sleep-wake 
patterns. Yet, results of this study and our previous work (Murray et al., 2015) suggest that 
adolescents with SB are vulnerable to the development of sleep disturbances that requires early 
detection through regular screening. Quick and effective multidimensional screening tools may 
include the BEARS (B = Bedtime Issues, E = Excessive Daytime Sleepiness, A = Night 
Awakenings, R = Regularity and Duration of Sleep, S = Snoring (Owens & Dalzell, 2005). 
Furthermore, modification of existing sleep measures to include items geared towards identifying 
modifiable and non-modifiable condition-related issues that underlie delayed bedtime routines 
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and disrupted nighttime sleep (e.g., lengthy medical management regimens) will help tailor 
interventions and clinical recommendations for youth with complex medical conditions such as 
pediatric SB.  
Given the risk for sleep disturbances in adolescents with SB and potential adverse effects 
of sleep on critical health outcomes, there is a clear need to increase prevention and intervention 
efforts in this population. Behavioral sleep interventions used in physically healthy populations 
have been used successfully in adolescents with autism and ADHD, and have been shown to ease 
daytime behavioral symptoms (e.g., Papadopoulos et al., 2015). Due to the complex medical 
presentation of SB, the intensity and specific components of behavioral sleep treatment will need 
to be modified to fit individual needs. Nevertheless, our results provide insight on potential 
treatment targets, including modification of nightly bedtime routines (i.e. preparing for bed and 
conducting nighttime medical management earlier), improving physical sleep environments (i.e., 
dim light, reduced noise, limiting TV or phone use), and increasing parental monitoring to 
establish earlier and consistent bedtimes/wake times. For youth with more significant insomnia 
issues (i.e., difficulties staying asleep), implementation of behavioral sleep techniques (e.g., 
stimulus control therapy) may also be appropriate. Identification of individual (e.g., 
developmental ability) and contextual barriers (e.g., socioeconomic status and family stress) 
impacting bedtime routines and nighttime sleep in this population will also be critical to help 
tailor sleep treatments in this population. Overall, prevention and intervention efforts aimed to 
ameliorate sleep disturbances may have a far-reaching impact on improving health and 
functioning in adolescents with SB. Increased recognition and treatment of sleep disturbances 
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represents a unique opportunity to improve overall health and well-being in individuals with SB 
and their families. 
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